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Abstract 
To maintain homeostasis, T lymphocytes die through caspase-dependent 
apoptosis. However, blockage of caspase activity in T lymphocytes does not increase cell 
survival. The loss of caspase 8 activity leads to programmed necrosis (necroptosis) upon 
T cell receptor (TCR) stimulation in T lymphocytes. Necroptosis is correlated with 
excessive macroautophagy, an intracellular catabolic process characterized by the 
sequestration of cytoplasmic compartments through double-membrane vacuoles. 
Meanwhile, the proper induction of macroautophagy is required for T lymphocyte 
survival and function. Cellular caspase 8 (FLICE)-like inhibitory protein (c-FLIP) 
promotes survival in T lymphocytes. c-FLIP suppresses death receptor-induced 
apoptosis by modulating caspase 8 activation. Whether this modulation plays a role in 
the regulation of necroptosis has yet to be studied. Additionally, overexpression of c-
FLIP reduces autophagy induction and promotes cell survival in cell lines. It remains 
unclear whether c-FLIP protects primary T lymphocytes by regulating the threshold at 
which autophagy occurs. In this study, c-FLIP isoform-specific conditional deletion 
models were used to study the role of c-FLIP in necroptosis and autophagy in primary T 
lymphocytes. 
Our results showed that the long isoform of c-FLIP (c-FLIPL) regulates 
necroptosis by inhibiting receptor interacting protein 1 (RIP-1). Upon TCR stimulation, 
  
v 
c-FLIPL-deficient T cells underwent RIP-1-dependent necroptosis. Interestingly, though 
previous studies have generally described necroptosis in the absence of caspase 8 
activity and apoptosis, pro-apoptotic caspase 8 activity and the rate of apoptosis were 
also increased in c-FLIPL-deficient T lymphocytes. Moreover, c-FLIPL-deficient T cells 
exhibited enhanced autophagy, which served a cytoprotective function.  
Apoptosis can be induced by either death receptors on the plasma membrane 
(extrinsic pathway), or the damage of the genome and/or cellular organelles (intrinsic 
pathway). Previous studies in c-FLIP-deficient T lymphocytes suggested that c-FLIP 
promotes cell survival in the absence of death receptor signals. Independent of death 
receptor signaling, mitochondria sense apoptotic stimuli and mediate the activation of 
caspases. Whether c-FLIP regulates mitochondrion-dependent apoptotic signaling 
remains unknown. Here, by deleting the c-Flip gene in mature T lymphocytes, we 
showed a role for c-FLIP in the intrinsic apoptosis pathway. In naïve T cells stimulated 
with the apoptosis inducer, c-FLIP suppressed cytochrome c release from mitochondria. 
Bim-deletion rescued the enhanced apoptosis in c-FLIP-deficient T cells, while inhibition 
of caspase 8 did not. Different from activated T cells, there were no signs of necroptosis 
in c-FLIP-deficient naïve T cells. Together, our findings indicate that c-FLIP is a key 
regulator of apoptosis, necroptosis and autophagy in T lymphocytes. 
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1. Introduction 
T lymphocytes face multiple checkpoints for life-or-death during their life span. 
Lymphoid precursor cells migrate from bone marrow to thymus, where they rearrange 
at the TCR loci and undergo positive selection and negative selection. Only T cell clones 
that are capable of responding to foreign antigens, but not self-reactive, survive and 
develop into mature CD4 and CD8 T lymphocytes (Palmer 2003). In the periphery, the 
resting T cells require interleukin-7 (IL-7) (Marrack et al. 2000) and tonic ‘tickling’ – the 
low-affinity engagement of TCR and self-peptide presented on the major 
histocompatibility complex (MHC) – for the maintenance (Rubtsov and Rudensky 2007). 
Once encountering specific antigens presented by antigen-presenting cells (APCs) with 
the appropriate co-stimulatory signals, T lymphocytes robustly proliferate and 
differentiate into populations of effector cells, including T helper cells (TH cells), 
inducible regulatory T cells (iTreg) and cytotoxic T lymphocytes (CTLs) (Johansson et al. 
2008). The majority of the effector T cells are eliminated during the contraction phase, 
leaving only a small fraction of them to develop into the memory T cells - cells that are 
specialized to rapidly respond to the same antigen. The size of the peripheral T 
lymphocyte pool is critical for a functional adaptive immune system; as a diverse T-cell 
repertoire is needed for protection against pathogens, while the body can only host a 
limited number of cells in the blood and lymphoid organs (Jameson 2002). Therefore, 
cell death is necessary for the proper development and function of T lymphocytes.  
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Different types of cell death are observed in T lymphocytes. Much attention has 
been given to apoptosis, a programmed cell-death (PCD). Apoptosis is shown to be 
essential for the development, homeostasis and function of T lymphocytes (Zhang et al. 
2005; Dunkle and He 2011). Another form of programmed cell death, necroptosis 
(programmed necrosis) is recently suggested to occur in activated T cells (Walsh and 
Edinger 2010). Additionally, several immunological studies revealed that the survival 
and proper function of T lymphocytes require autophagy, a conserved intracellular 
catabolic mechanism (Pua and He 2009a). These three processes, as well as their complex 
interplay, are essential for the proper T cell response in adaptive immunity.  
1.1 Apoptosis in T lymphocytes 
1.1.1 The mechanism of apoptosis 
Biologists are so busy deciphering the myth of life that death has not been 
recognized as a regulated process until 1970s, when Kerr et al. characterized apoptosis: 
an active, programmed form of cell death with distinct morphological features, 
including nuclear condensation, cytoplasm shrinkage (pyknosis), cellular membrane 
blebbing, membrane-bound apoptotic body formation and subsequent engulfment by 
neighboring phagocytes (Kerr et al. 1972). During apoptosis induction, chromosomal 
DNA is initially degraded at the internucleosomal linker site to produce 50-200 kb DNA 
fragments. This process, termed apoptotic DNA fragmentation, is one of the biochemical 
hallmarks of apoptosis (Danial and Korsmeyer 2004). Apoptotic cells also redistribute 
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phosphatidylserine (PS) residues to the cell surface as an ”eat me” signal (Fadok et al. 
1998). However, under certain conditions PS exposure can be reversible, for instance in 
granulocytes and monocytes after the incubation of hypotonic 0.2% NaCl or NH4Cl 
lysing solution used to remove red blood cells (Yang et al. 2002). Cells in the late stage of 
apoptosis in vitro eventually lose the plasma membrane integrity in the absence of co-
cultured phagocytes. Therefore, the evaluation of apoptosis can be performed by 
combining the PS staining on the cell surface and the incorporation of vital dyes that are 
excluded in intact cells (i.e. 7-AAD). 
1.1.1.1 Caspases 
The execution of apoptosis requires the members of the cysteine aspartyl-specific 
proteases family, abbreviated as “caspases”. Not all the members of caspase family are 
involved in apoptosis. For example, the first identified caspase, caspase 1 (also known as 
interleukin 1 converting enzyme, ICE), mediates pro-inflammatory pyroptosis in innate 
immunity (Bergsbaken et al. 2009). The caspases with pro-apoptotic activities in 
mammalian cells are divided into two groups based on their function: the initiator 
caspases (caspase 2, 8, 9, 10) and the effector caspases (caspase 3, 6, 7). All caspases are 
synthesized as catalytic inactive form (referred as zymogens). The proteolytic cleavages 
at the specific Asp residues lead to the release of a large (~20kD) and a small (~10kD) 
subunits, which then forms the active enzyme together (Cohen 1997). The initiator 
caspases undergo auto-proteolysis, but the intra-chain cleavage dose not greatly increase 
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their catalytic activity and may not be required for their activation (Stennicke et al. 1999). 
The full activation of initiator caspases generally requires the formation of a multi-
component complex serving as the activating platform. For example, caspase 8 
activation requires the formation of death–inducing signaling complex (DISC) and 
caspase 9 activation occurs at the multiple-component apoptosome (Krammer et al. 
2007; Riedl and Salvesen 2007). Activated initiator caspases subsequently cleaves the 
effector caspases at the Asp residues to generate the active form of effector caspases 
(Riedl and Shi 2004). Upon activation, effector caspases amplify the magnitude of death 
signals by self-cleavage, and conduct a broad scaled proteolysis on “cell-death 
substrates”.  
The destruction of “cell-death substrates” by active effector caspases leads to the 
apoptotic morphology and eventually cell death. For instance, inhibitor of the caspase-
activated DNase (ICAD) is cleaved by caspase 3 and 7 to allow the transportation of 
endonuclease to the nucleus for DNA fragmentation (Wolf et al. 1999). At the same time, 
DNA-dependent protein kinase (DNA-PK), an enzyme for double-strand-break repair, is 
inactivated as the catalytic subunit is cleaved by caspase 3 (Itoh and Horio 2001). Active 
caspase 3 also cleaves poly(ADP-ribose) polymerase (PARP) to cease DNA repair, as 
well as to spare the NAD and ATP normally consumed by active PARP (Simbulan-
Rosenthal et al. 1998; Boulares et al. 1999). Lamin A and C are cleaved by caspase 3 and 
6, leading to chromatin condensation and nuclear shrinkage (Ruchaud et al. 2002; 
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Krammer et al. 2007). During apoptosis, messenger RNA splicing is blocked, as caspase 
3 cleaves U1-70, the protein component of U1 small nuclear ribonucleoprotein particles 
for the processing of precursor mRNAs (Slee et al. 2001). The cleavage of cytoskeletal 
proteins, such as actin, gelsolin, fodrin and RAS homologue (RHO)-associated coiled-
coil-containing protein kinase 1 (ROCK-1), results in plasma blebbing and the generation 
of apoptotic bodies (Cohen 1997; Mashima et al. 1999; Krammer et al. 2007). Past the 
point of no return, now the cell successfully commits suicide. 
Based on the original trigger of caspase activation, two signaling cascades are 
termed: the intrinsic apoptotic pathway, which congregates at the outer membrane of 
mitochondria; and the extrinsic apoptotic pathway, which senses extracellular death 
signals. Though initiated and regulated by different factors, both pathways eventually 
lead to the cleavage and activation of effector caspases.  
1.1.1.2 The intrinsic pathway 
The intrinsic pathway is triggered by intracellular stimuli, such as DNA damage, 
endoplasmic reticulum (ER) stress, or growth factor deprivation. Mitochondrial outer 
membrane permeabilization (MOMP) is the crucial process of intrinsic pathway (Bender 
and Martinou 2013). MOMP is primarily regulated by the members of Bcl-2 family. The 
founder of this family, B-cell lymphoma-2 (Bcl-2) was first cloned at the chromosomal 
breakpoint in the t(14;18) translocation-bearing follicular B-cell lymphoma (Tsujimoto et 
al. 1984). Bcl-2 contains four conserved -helical segments, named Bcl-2 homologous 
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domains (BH domains). Other Bcl-2 family members were identified by the sequence 
homology to BH domains (Gross et al. 1999). Based on the functional and structural 
differences, Bcl-2 family is further divided into three subfamilies: anti-apoptotic BH1-4 
subfamily, pro-apoptotic BH1-3 subfamily and pro-apoptotic BH3-only subfamily 
(Figure 1A).  
 
 
Figure 1: Bcl-2 family members  
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Figure 1. (A) Schematic structures of Bcl-2 family members. TM: transmembrane; 
Bcl-xL: B-cell lymphoma-extra large; Mcl-1: myeloid cell leukemia-1; A1: Bcl-2-related 
protein A1; Bax: pro-apoptotic Bcl-2-associated X protein; Bak; Bcl-2-antagonist/killer-1; 
Bok: Bcl-2 related ovarian killer; Bim: Bcl-2-interacting mediator of cell death; Bid: BH3-
interacting domain death agonist; Bik: Bcl-2-interacting killer; Bad: Bcl-2 antagonist of 
cell death; Bmf: Bcl-2-modifying factor; Noxa: Phorbol-12-myristate-13-acetate-induced 
protein 1; Puma: p53 upregulated modulator of apoptosis. (B) Two major models for the 
role of BH3-only members during apoptosis induction. The indirect activation model 
proposes that anti-apoptotic BH1-4 proteins constantly suppress Bax and Bak; and the 
competitive interactions of BH3-only proteins with anti-apoptotic BH1-4 proteins release 
Bax and Bak from the inhibition. Bax and Bak are auto-activated once they are 
unconstrained. The direct activation-depression model suggests that activation of Bax 
and Bak requires the aids of some BH3-only proteins. Anti-apoptotic BH1-4 proteins 
promote cell survival by inhibiting both Bax/Bak and pro-apoptotic BH3-only proteins.  
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BH1-3 subfamily members contain BH1, BH2 and BH3 domains and a 
transmembrane domain. Three proteins are in this group: Bax, Bak and Bok. Bax and 
Bak are broadly expressed in tissues and organs (Oltvai et al. 1993; Kiefer et al. 1995), 
while the expression of Bok is restricted to the reproductive system, including ovary, 
testis and uterus (Hsu et al. 1997). Bax and Bak are functionally redundant for apoptosis 
to occur during the embryonic development in mice (Lindsten et al. 2000). BakBax 
fibroblasts show resistance to MOMP after multiple intrinsic apoptotic stimuli, including 
tBid transfection, apoptosis inducing drugs and ultraviolet (UV) radiation (Wei et al. 
2001). During apoptosis, Bak and Bak are believed to undergo conformational change 
and oligomerize to facilitate cytochrome c release. Recent protein structure study has 
revealed that the BH3 domain of Bak is transiently exposed upon apoptotic stimuli and 
subsequently interacts with the hydrophobic groove of another activated Bak to form a 
symmetric dimmer (Dewson et al. 2008; Dewson and Kluck 2009). The same mechanism 
applies to the dimerization of Bax (Czabotar et al. 2013). The Bak or Bax dimmers likely 
associate with each other via other regions away from BH3:groove, forming a high-
ordered oligomer (Dewson and Kluck 2009). The role of Bok in apoptosis is yet unclear. 
Though overexpression of Bok promotes apoptosis, Bok may not be a functional 
analogue to Bak and Bax, as enforced expression of Bok cannot restore apoptosis 
induction in the apoptosis resistant BakBax fibroblasts (Echeverry et al. 2013).  
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Bax- and Bak-mediated MOMP allows the release of several pro-apoptotic 
proteins from the mitochondrial intermembrane space (IMS) to cytosol. Identified 
proteins that are released during MOMP are cytochrome c, second mitochondria-
derived activation of caspase/direct IAP-binding protein with low pI (Smac/Diablo) and 
high temperature requirement protein A2 (Htra2/Omi) (Tait and Green 2010). In the 
cytosol, cytochrome c binds to apoptotic protease activating factor-1 (Apaf-1). This 
interaction leads to the structural alteration and oligomerization of Apaf-1, forming the 
apoptosome: a 1.4 MD seven-member caspase activating complex (Riedl and Salvesen 
2007). The apoptosome recruits pro-caspase 9 through its caspase-recruitment domain 
(CARD) and serves as a reaction platform for caspase 9 activation. The active caspase 9 
then proteolytically cleaves and activates effector caspases, such as caspase 3, 6 and 7. X-
linked inhibitor of apoptosis protein (XIAP) inhibits the activation of caspase 3, 7 and 9 
(Deveraux et al. 1999; Suzuki et al. 2001). Smac/Diablo and Htra2/Omi released from 
mitochondria block the activity of XIAP to promote the execution of apoptosis (Tait and 
Green 2010). 
Anti-apoptotic BH1-4 subfamily contains Bcl-2, Bcl-w, Bcl-xL, Mcl-1 and A1, 
which contain all four BH domains and a C-terminal transmembrane domain. The anti-
apoptotic members generally inhibit Bax and Bak activation (Youle and Strasser 2008). In 
healthy cells, Bak locates on the outer membrane of mitochondria. Mcl-1 and Bcl-xL 
constitutively interact with Bak via the BH3 domain, thus suppressing Bak activation 
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(Cuconati et al. 2003; Willis et al. 2005). Bax, on the other side, resides in the cytosol 
compartment as a monomer in the absence of death signals (Hsu and Youle 1998). In 
response to cellular stress, Bax is “semi-activated” and translocates to mitochondria, 
where its further oligomerization is suppressed by Bcl-2 (Korsmeyer et al. 1993; Ruffolo 
and Shore 2003). Therefore, the formation of Bak/Bax oligomer on the outer membrane 
of mitochondria requires the downregulation of anti-apoptotic BH1-4 proteins. 
Additionally, members of the anti-apoptotic BH1-4 subfamily protect cell from death 
beyond restraining Bax and Bak. Bcl-2 associates with both Apaf-1 and caspase 9, and 
Bcl-xL inhibits Apaf-1-dependent activation of caspase 9 (Hu et al. 1998). Bcl-2 even 
provides protection independent of apoptosome, as overexpression of Bcl-2 promotes 
cell survival in Apaf-1 and caspase-9 cells (Ekert et al. 2004; Marsden et al. 2006).  
BH3-only subfamily includes Bid, Bim, Bad, Bik, Bmf, Noxa and Puma. The BH3-
only members act as sentinels instead of executioners in apoptosis induction. Most BH3 
members inhibit anti-apoptotic Bcl-2 family members to promote apoptosis (Figure 1B). 
For example, Noxa interacts with Mcl-1, displays Bak and lifts the inhibition on Bak for 
apoptosis-inducing dimerization (Willis et al. 2005). Whether BH3-only proteins directly 
assist Bax/Bak during MOMP is debatable (Youle 2007). Chemically stabilized BH3 -
helices of Bim and Bid bind to Bax and trigger its activation (Walensky et al. 2006; Youle 
2007). However, some studies showed that Bim, Bid and Puma are dispensable for 
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Bax/Bak-mediated apoptosis (Willis et al. 2007). The two models of BH3-only members 
promoting apoptosis are illustrated in Figure 1B. 
1.1.1.3 The extrinsic pathway  
The extrinsic pathway is initiated by the cell surface death receptors upon the 
ligation of their ligands. Death receptors (DRs) belong to the tumor necrosis factor 
receptor (TNFR) superfamily and contain a death domain (DD). DD locates in the 
cytoplasmic part of the DRs and mediates the recruitment of the adaptor protein Fas-
associated via death domain protein (FADD) and/or TNFR type 1-associated death 
domain protein (TRADD) following trimetric ligand engagement (Locksley et al. 2001). 
Among the 8 homologous DRs identified in the TNFR superfamily, so far 6 of them are 
shown to be capable of inducing apoptosis. These DRs includes Fas (CD95), TNFR1, 
death receptor 3 (DR3), death receptor 6 (DR6), TNF-related apoptosis inducing ligand 
receptor 1 (TRAILR1/DR4), and TRAILR2 (DR5) (Tartaglia et al. 1991; Suda et al. 1993; 
Chinnaiyan et al. 1996; Schneider et al. 1997; Pan et al. 1998). It needs to be noted that DR 
signaling does not always lead to apoptosis. For example, apoptosis is prohibited once 
the engagement of TNFR1 to TNF- successfully triggers NF-B signaling and 
subsequent upregulation of anti-apoptotic proteins, such as c-FLIP (Wang et al. 1998; 
Micheau et al. 2001; Micheau and Tschopp 2003). 
Stimulation of Fas initiates the formation of a membrane-bound receptor 
complex referred to as the death-inducing signaling complex (DISC) (Lavrik and 
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Krammer 2012). Upon Fas-FasL interaction, the cytoplasmic tail of Fas recruits cytosolic 
adaptor protein FADD (Chinnaiyan et al. 1995). FADD contains a C-terminal DD, which 
mediates its association with Fas, and a N-terminal death effector domain (DED), 
through which FADD recruits DED containing pro-caspase 8, pro-caspase 10 and c-FLIP 
(Kim 2002). The catalytic cleavage of pro-caspase 8 in DISC generates the two subunits 
of active caspase 8: p10 and p18 (Budd et al. 2006; Lavrik and Krammer 2012). Recently, 
a cytosolic Fas signaling complex is identified, which is termed complex II. Complex II 
does not contain surface receptor Fas but the rest components of DISC, and mediates the 
activation of caspase 8 as well (Lavrik et al. 2008). TRAILR1 and TRAILR2 engagements 
also lead to the formation of DISC, to which adaptor protein TRADD is recruited along 
with FADD (Schneider et al. 1997; Jin et al. 2004). c-FLIP directly regulates pro-caspase 8 
and pro-caspase 10 activation at the DISC. The role of c-FLIP in death receptor-induced 
apoptosis will be introduced in details in 1.5.1 
TNF-/TNFR1 ligation-mediated apoptosis involves two sequential signaling 
complexes. The engagement of TNFR1 leads to trimerization of the receptors and 
recruitment of adaptor protein TRADD. Additionally, DD-containing Serine/threonine 
kinase receptor interacting protein 1 (RIP-1), TNF receptor-associated factor 2 (TRAF2) 
and cellular inhibitor of apoptosis protein-1 (c-IAP-1), c-IAP-2 are recruited. Together 
they form the plasma membrane associated complex I and activate NF-B/JNK signaling 
(Wertz and Dixit 2010). TNFR1 is internalized after TNF- ligation (Schutze et al. 1999). 
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In cytosol, pro-caspase 8 and pro-caspase 10 are recruited to TRADD and RIP-1, forming 
the apoptosis-inducing complex, termed complex II. NF-B upregulates the expression 
of anti-apoptotic protein c-FLIPL, which suppresses the formation of complex II. 
Therefore, whether TNFR1 induces NF-B response or apoptosis depends on the cellular 
level of anti-apoptotic proteins (Micheau and Tschopp 2003).  
1.1.1.4 The crosstalk of intrinsic pathway and extrinsic pathway 
A long debate revolves around the question whether death receptor-induced 
apoptosis requires the Bcl-2 family member-controlled MOMP. One scenario is that 
DISC can activate the initiator caspases (caspase 8 and 10), while apoptosis cannot be 
executed because the cellular XIAP blocks the caspase 3 activation and maturation 
(Sprick and Walczak 2004). This augment is supported by the fact that the activation of 
caspase 8 does not always result in apoptosis, especially in the hematopoietic system 
(Galluzzi et al. 2008). The BH3-only protein Bid is shown to be the link of death receptor 
ligation-induced (extrinsic) and mitochondrion-dependent (intrinsic) apoptotic 
pathways. Bid is a specific substrate of active caspase 8 upon Fas-FasL ligation. The 
product after the cleavage, truncated Bid (tBid) translocates to the outer membrane of 
mitochondria, where it induces the release of cytochrome c (Li et al. 1998; Luo et al. 
1998) and Smac/Diablo (Li et al. 2002). Bcl-2 and Bcl-xL regulates the function of Bid, as 
well as the release of Smac/Diablo from IMS (Li et al. 1998; Luo et al. 1998; Sun et al. 
2002b). Though cytosolic Bid is shown to interact with Bax, caspase 8-cleaved tBid 
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preferentially utilizes Bak instead of Bax for triggering MOMP (Cartron et al. 2003). The 
crosstalk of extrinsic and intrinsic apoptotic pathways is illustrated in Figure 2.  
Though death receptor signaling can lead to cytochrome c release and 
apoptosome formation, apoptosome is not always required for the execution of DR-
induced apoptosis. For example, thymocytes derived from Apaf-1 and caspase 9 mice 
are not resistant to Fas-induced apoptosis (Hakem et al. 1998; Yoshida et al. 1998). 
Caspase 8/Bid also mediates the release of Smac/Diablo, which antagonizes the XIAP to 
remove its inhibition on caspase 3 and 7 (Chai et al. 2000; Du et al. 2000; Srinivasula et al. 
2000; Verhagen et al. 2000). Therefore, Bid is probably essential for death receptor-
mediated apoptosis in cells with high level of anti-apoptotic protein XIAP. Based on the 
requirement of Bid during Fas-induced apoptosis, cells are divided into two groups: 
type I cells that can be killed by Fas signal in the absence of Bid, and type II cells that 
requires Bid for Fas-mediated apoptosis (Kaufmann et al. 2012).  
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Figure 2: The interplay of intrinsic and extrinsic apoptotic pathways.  
  16 
 
Figure 2. The intrinsic pathway is initiated by cellular stress or damage to the 
genome. Upon death stimuli, cellular Bax Translocates to the mitochondria, where Bax 
and Bak oligomerize to induce MOMP. Cytochrome c, Smac/Diablo and Htra2/Omi are 
then released from the intermembrane space of mitochondria. Cytochrome c binds to 
cytosolic Apaf-1 and changes the structure of Apaf-1 with the aids of dATP. 
Consequently, the seven-member apoptosome is formed, which leads to the activation of 
caspase 9. The extrinsic pathway is triggered by death receptors on the plasma 
membrane. FasL-Fas interaction triggers the formation of death-inducing signaling 
complex (DISC), which serves as the docking site for the self-cleavage and activation of 
caspase 8. TRAIL-DR4/DR5 ligation initiates similar death signaling, though TRADD is 
also recruited to DISC (not shown in this figure). The TNF-/TNFR1 association may 
also lead to apoptosis, which involves the formation of the intracellular complex II 
(illustrated in Figure 3). Active caspase 8 cleaves pro-apoptotic protein Bid. Truncated 
Bid relocates to mitochondria and promotes MOMP. Both active caspase 8 and caspase 9 
cleave the effector caspases: caspase 3, 6 and 7. Active caspase 3, 6 and 7 execute the 
morphological and biochemical alterations for apoptosis. The activation of caspase 9 and 
caspase 3/7 are inhibited by XIAP. Smac/Diablo released from mitochondria blocks the 
activity of XIAP to promote apoptosis (To simply the illustration, caspase 10 and c-FLIPS, 
which are expressed in human but not in mice, are not shown in this figure). 
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1.1.2 Apoptosis in T cell homeostasis  
1.1.2.1 Apoptosis in thymocyte development 
Death is not only a high cost but also a necessity of living, especially in the 
immune system. Apoptosis is required for the proper thymocyte development. 
Reconstituted mice with BakBax hematopoietic cells show disrupted development 
and selection of thymocytes. BakBax thymocytes are resistant to both death-by-
neglect and antigen receptor-induced apoptosis (Rathmell et al. 2002). Similarly, Bim-
deficient mice showed autoimmunity caused by defective negative selection in 
thymocytes (Bouillet et al. 1999).  
In the development battlefield of the thymus, thymocytes actively upregulate 
and utilize different anti-apoptotic Bcl-2 family members to pass the “checkpoint” at 
different developmental stages. For example, Bcl-2-deficiency leads to the blockage in 
the progression from double negative (DN) to double positive (DP) stage in mice older 
than approximately three weeks (Nakayama et al. 1993; Veis et al. 1993). The reason for 
the age-related requirement of Bcl-2 in thymocyte development may be attributed to the 
shift from fetal liver-derived to bone marrow-derived progenitors and their different 
dependence on Bcl-2 (Matsuzaki et al. 1997). Bcl-xL promotes the survival of double DP 
thymocytes, though loss of Bcl-x gene does not lead to defective thymocyte 
development, but only reduced cellularity in thymus (Zhang and He 2005a). Mcl-1 is 
required for thymocytes development and survival at both DP and single positive (SP) 
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stage (Opferman et al. 2003; Dzhagalov et al. 2008). Genetic study revealed that Bcl-xL 
and Mc-1 function redundantly in the development of DP thymocytes. Deletion of either 
Mcl-1 or Bcl-x at the late DN to DP stage (through CD4-Cre) marginally impairs the 
cellularity of DP thymocytes. However, Bcl-xf/f Mcl-1f/f CD4-Cre mice display a severe 
reduction in DP compartment (Dzhagalov et al. 2008). On the other side, overexpression 
of Bcl-2 fails to rescue the thymocyte developmental defect in the T-cell specific Mcl-1-
deficient mice (Dunkle et al. 2010), which suggests Mcl-1 and Bcl-2 function in different 
pathways in the regulation of thymocyte development. 
1.1.2.2 Apoptosis in T cell maintenance 
Naïve T cells are long-lived resting cells that generally do not proliferate. The 
quiescence of naïve T cells is regulated by the transcription factor, lung Kruppel-like 
factor (LKLF), which is induced during the maturation of SP thymocytes (Kuo et al. 
1997). Though naïve T cells do not undergo clonal expansion, the maintenance of 
peripheral T cells requires the transient, low affinity engagement of TCR with self-
ligands presented on MHC. In the absence of MHC-II or MHC-I molecule, periphery 
CD4 or CD8 T lymphocytes fail to survive, respectively (Kirberg et al. 1997; Nesic and 
Vukmanovic 1998). Cytokine IL-7 is also required for the survival of naïve T cells (Fry 
and Mackall 2001). It is generally believed that Bcl-2 family proteins are the major 
downstream effector molecules regulated by IL-7 (Zhang et al. 2005). IL-7 signaling 
promotes cell survival by upregulating the expression of anti-apoptotic protein Bcl-2 
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and Mcl-1 (Kim et al. 1998; Opferman et al. 2003), as well as downregulating the 
expression of Bax and Bad (Kim et al. 1998; Khaled et al. 2002; Li et al. 2004). Bim is also 
the sensor of the IL-7 signal. Deletion of Bim partially rescues the death phenotype 
driven by IL-7 deprivation in peripheral T cells. IL-7 withdrawal does not alter the 
transcription or protein level of Bim, but alters the association of Bim with Mcl-1 (Li et 
al. 2010). Additionally, stress-induced apoptosis is also mediated by Bcl-2 family 
members in T lymphocytes. Puma and Bim contributes significantly to apoptosis 
induction in response to -radiation and glucocorticoid in T cells (Erlacher et al. 2005). 
Different anti-apoptotic Bcl-2 family members function differently in T cells. Bcl-
2 and Mcl-1 are required for the survival of mature T lymphocytes (Nakayama et al. 
1993; Veis et al. 1993; Opferman et al. 2003; Dunkle et al. 2011). Mcl-1 protects cell 
survival by antagonizing Bak in the presence of IL-7 in resting T lymphocytes. During 
IL-7 deprivation, Bcl-2 and Mcl-1inhibit the BH3-only protein Bim to promote cell 
survival (Dunkle et al. 2011). Bcl-xL, however, is dispensable for the survival of primary 
T cells (Zhang and He 2005a).  
1.1.2.3 Apoptosis in activated T lymphocytes: AICD and ACAD 
While naïve T cells are generally resistant to apoptosis stimuli except for IL-7 
deprivation, activated T cells are prone to apoptosis. The different threshold of 
sensitivity to apoptosis induction is required for a functional adaptive immune system. 
After clonal expansion, the majority of activated T cells need to be eliminated to 
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maintain T cell homeostasis, as well as to avoid excessive inflammation and 
autoimmunity. Defective apoptosis in activated T cells can be very problematic. For 
example, the BakBax T cells in periphery show reduced apoptotic rate upon 
endogenous superantigen-induced elimination, which leads to accumulated memory T 
cells in the spleen and splenomegaly (Rathmell et al. 2002). Activated T cells that are 
restimulated in the absence of appropriated co-stimulatory signals promptly die through 
apoptosis, a process known as activation-induced cell death (AICD). In vitro, AICD can 
be mimicked by restimulating TCR-activated T cells by anti-CD3 or PMA/ionomycin in 
the presence of IL-2 (Krammer et al. 2007). AICD is majorly mediated by death receptor 
ligation. A death receptor-independent, autonomous apoptosis also occurs in activated T 
cells. This type of cell death is caused by the lack of appropriate survival signals and 
termed activated cell autonomous death (ACAD) (Krammer et al. 2007). 
AICD usually involves the signals from death receptors, including Fas, TNFR1, 
TRAILR1 and TRAILR2 (Krammer et al. 2007). Fas plays a critical role in maintaining 
lymphocyte homeostasis via AICD (Strasser et al. 2009). Human carrying dysfunctional 
Fas develop a lymphoproliferative autoimmune disease. Similar phenotype is observed 
in lpr/lpr mice, a mutant in which functional Fas is not expressed (Watanabe-Fukunaga 
et al. 1992; Rieux-Laucat et al. 1995). Restimulation of already activated T cells leads to 
the upregulation of FasL and Fas-dependent apoptosis (Green et al. 2003). Meanwhile, 
IL-2 signaling downregulates the cellular level of c-FLIP protein, the cellular inhibitor of 
  21 
death receptor signaling, to sensitize activated T cells to Fas-mediated apoptosis 
(Algeciras-Schimnich et al. 1999). BH3-only protein Bim is also involved in the execution 
of AICD. T cells upregulate the expression of Bim after polyclonal or specific TCR 
stimulation, and the blockage of Bim expression rescues T cells from AICD (Sandalova et 
al. 2004). In vivo study showed that Fas and Bim mediated the CD8 T cell contraction 
concurrently. Bcl2l11lpr/lpr mice showed 100 fold more antigen-specific memory T 
cells than wild type mice after lymphocytic choriomeningitis virus (LCMV) infection 
(Weant et al. 2008). Mice lacking both Bim and Fas developed systemic lupus 
erythematosus (SLE)-like phenotype by 16 weeks of age, which is much earlier than the 
onset of autoimmunity in Bim-deficient or lpr/lpr mice. The autoimmunity in 
Bcl2l11lpr/lpr mice is mediated not only by the apoptosis-resistant T lymphocytes, but 
also overactive APCs (Hutcheson et al. 2008). 
ACAD is mediated by the pro-apoptotic Bcl-2 family members. Though activated 
T cells do not alter the protein level of Bim, Bim is the major mediator of apoptosis in 
activated T cells in the absence of Fas or TNFR1 (Hildeman et al. 2002). Bim is prohibited 
by Bcl-2 and Bcl-xL in healthy cells, while in activated T cells Bim is preferentially 
associated with Bcl-xL, but not Bcl-2 (Zhu et al. 2004). The role of IL-2 is complicated in 
the survival of activated T cells. While IL-2 signaling contributes to AICD by 
downregulating anti-apoptotic protein c-FLIP, IL-2 deprivation leads to the 
upregulation of Puma and ACAD (You et al. 2006).  
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Altogether, apoptosis plays an essential role in the T cell development and 
homeostasis. Interestingly, caspase 8- and FADD-deficient T cells, in which the extrinsic 
apoptotic pathway is impaired, do not show prolong survival or accumulate in the 
periphery. Instead, they are eliminated promptly upon TCR stimulation (Osborn et al. 
2010; Ch'en et al. 2011). A type of caspase-independent programmed cell death is 
observed in those cells, which will be introduced in details in the following section. 
1. 2 Necroptosis in the immune system 
Since the identification of apoptosis, “necrosis” has been considered as a passive 
way of cell death, an accidental consequence of “intolerable” micro-environmental 
stress. Morphologically, necrosis is characterized by the increased cell volume (oncosis), 
swelling of the organelles, lack of modifications of the nucleus and the ultimately 
disruption of the plasma membrane prior to phagocytosis (Kroemer et al. 2009; 
Vandenabeele et al. 2010). Recently, data emerged to show that necrosis can be 
associated with a sequence of controlled intracellular events including increased 
production of reactive oxygen species (ROS), ATP depletion, peri-nuclear clustering, and 
activation of specific proteases, such as calpains and cathepsins (Golstein and Kroemer 
2007). In 2000, Holler et al. described a type of RIP-1-dependent necrotic cell death in 
human and murine T lymphocytes. Normally, FasL-Fas ligation induces caspase-
dependent apoptosis. However, pan-caspase inhibitor z-VAD-fmk treatment on T cells 
triggers severe cell death. The dying cells showed none of the typical apoptotic 
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signatures, such as chromatin condensation or oligonucleosomal DNA fragmentation, 
but necrotic morphological features, such as early plasma membrane damage and 
shortened time frame between phosphatidylserine exposure on the surface and 
membrane rupture. This caspase-independent cell death requires RIP-1, which is 
recruited to the DISC (Holler et al. 2000). Similar phenotypes are detected in other 
experimental systems, usually when caspase activities are demolished. The term 
“necroptosis” is proposed then to describe this regulated, serine/threonine kinase RIP-1-
dependent necrosis to distinguish it from fortuitous necrosis caused by non-
physiological stress, such as base/acid treatment and freeze-thaw circles (Galluzzi and 
Kroemer 2008; Kroemer et al. 2009). 
1.2.1 The mechanism of necroptosis 
1.2.1.1 Initiation of necroptosis: plasma membrane bound and cytosolic receptors 
Necroptosis can be triggered by the ligation of death receptor to their ligands on 
plasma membrane. In wild type cells, death receptor ligation almost always triggers the 
cascades that mediate apoptosis (though apoptosis may not be executed in the end). 
However, when caspase activities are suppressed, either through addition of caspase 
inhibitors or genetic deletion of certain molecules in the caspase-activating pathway, 
ligation of death receptors causes the regulated cell death featuring a necrotic 
morphology. Several death receptors can trigger necroptosis, including Fas, TNFR-1, 
TNFR-2, TRAILR-1, and TRAILR-2 (Vercammen et al. 1997; Holler et al. 2000; Los et al. 
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2002; Chan et al. 2003; Vanlangenakker et al. 2011). Though TNFR2 does not contain a 
cytoplasmic death domain, it mediates necroptosis through degrading TRAF2 to 
enhance the death signal of TNFR1 (Chan and Lenardo 2000). Transcription inhibitors, 
such as actinomycin D (ActD) also sensitized cells to TNF--triggered necroptosis 
(Vercammen et al. 1997; Los et al. 2002). Transcriptional inhibition may promote 
necroptosis by blocking the synthesis of protective molecules, which will be introduced 
in details in 1.2.1.3.  
Pathogen recognition receptors (PRRs) can also initiate necroptosis. Similar death 
receptor-induced necroptosis, necroptosis induced by PPRs requires a second 
“inhibitory signal”, which switches the cells from “default” survival/apoptosis to 
necrotic cell death. Caspase inhibitor z-VAD-fmk sensitizes mouse fibroblasts and 
macrophage to RIP-3-dependent necrosis when Toll-like receptor 3 (TLR3) is activated 
by double strand RNA (dsRNA) or poly (I:C) (Li and Beg 2000; Kalai et al. 2002; He et al. 
2011). TLR3 activation also leads to necroptosis in cells lacking caspase 8, FADD or 
functional c-IAPs (Kalai et al. 2002; Feoktistova et al. 2011). TLR4 ligand 
lipopolysaccharide (LPS) induces RIP-1/RIP-3-dependent necroptosis in z-VAD-fmk-
treated macrophages, especially when NF-B activation is blocked (Ma et al. 2005; He et 
al. 2011). Cellular ribonucleic acid sensor retinoic acid-inducible gene 1 (RIG-I) is a 
potential necroptosis initiator. Caspase 8-mediated cleavage of the RIP-1 protein is 
  25 
mediated by RIG-I signaling (Rajput et al. 2011). In the absence of caspase activity, the 
inhibition on RIP-1 may be lost and necroptosis may be provoked. 
In addition, some types of cells are very susceptible to necroptosis. Pan-caspase 
inhibitor z-VAD-fmk treatment induces necroptosis in L929 cells in the absence of death 
receptor or PRR ligation (Yu et al. 2004). Certain viruses are capable of encoding caspase 
inhibitor to induce necroptosis and inhibit apoptosis in infected cells, such as CrmA 
encoded by cowpox and B13R encoded by vaccinia virus (Ray and Pickup 1996; Chan et 
al. 2003; Oberst et al. 2011).  
1.2.1.2 The necrosome: RIP-1 and RIP-3 
Serine/threonine kinase receptor interacting protein 1 (RIP-1/RIPK1) was first 
identified in the yeast two-hybrid screening as a binding protein for the intracellular 
domain of Fas (Stanger et al. 1995). RIP-1 contains a death domain, a RIP-1 homotypic 
interaction motif (RHIM) and a protein kinase domain. Through its death domain, RIP-1 
is recruited to death receptor signaling complex. RIP-1 is dispensable for apoptosis 
induction (Hsu et al. 1996; Ting et al. 1996; Dohrman et al. 2005a), but required for the 
pro-survival NF-B signaling induced by TNFR1 (Ting et al. 1996; Meylan et al. 2004) 
Rip-1 newborn mice died 1 to 3 days post-birth, due to extensive apoptosis in 
lymphocytes and adipocytes (Kelliher et al. 1998). However, emerging data suggested 
that RIP-1 is also a pro-death factor, as the kinase activity of RIP-1 mediates necroptosis 
(Degterev et al. 2008). The pro-survival NF-B inducing activity and the pro-necroptotic 
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kinase activity of RIP-1 are likely to be independent, as attenuated NF-B activation has 
no impact on TNF--induced necroptosis in L929 cells (Vanlangenakker et al. 2011). 
The posttranslational modification on RIP-1 is the decision-maker of its function. 
RIP-1 can be phosphorylated and ubiquitinated in response to TNF-. The kinase 
activity of RIP-1 is not the requisite factor of its ubiquitination (Lee et al. 2004). In TNFR1 
complex I, c-IAP is stabilized by TRAF2 and mediates the ubiquitination of RIP-1 
(Bertrand et al. 2008; Csomos et al. 2009). Poly-ubiquitination at Lsy377 transforms RIP-1 
to the docking site for NF-B essential modulator (NEMO), the regulator subunit of the 
IB kinase complex (Ea et al. 2006). Ubiquitinated RIP-1 also activates transforming 
growth factor--activated kinase 1 (TAK1) (Lee et al. 2004; Hacker and Karin 2006). The 
regulatory molecule of TAK1, TAK-binding protein 2 (TAB2) associates with 
ubiquitinated RIP-1 upon TNF- stimulation (Kanayama et al. 2004). This recruitment 
leads to the formation of NF-B activating TAK1-TAB2-TAB3 complex following TNF- 
ligation (Wertz and Dixit 2010). The Lys377 is the critical ubiquitination site for RIP-1. 
Mutation of this residue to Arg abolishes TNF--dependent RIP-1 ubiquitination and 
NF-B signaling (Li et al. 2006).  
The Lys 63-linked polyubiquitin moieties on the Lys377 of RIP-1 prohibit the 
association of RIP-1 to caspase 8 (O'Donnell et al. 2007). Cylindromatosis (CYLD) and 
A20 mediate the deubiquitination of RIP-1 (Harhaj and Dixit 2012), allowing the 
deubiquitinated RIP-1 to recruit pro-caspase 8 (Rajput et al. 2011). Deubiquitinated RIP-1 
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may recruit TRADD, FADD and pro-caspase 8 to form the death-inducing complex II, in 
which RIP-1 either undergoes proteolytic cleavage by caspase 8 or recruits RIP-3 to 
initiate necroptotic signaling. CYLD is shown to be a requisite factor for necroptosis 
induction (Hitomi et al. 2008; O'Donnell et al. 2011). The role of A20 in the regulation of 
necroptosis remains unclear. One study showed that A20 suppresses cell death in TNF- 
treated L929 cells (Vanlangenakker et al. 2011). As A20 is also a negative regulator of 
apoptosis, whether A20 regulate necroptosis in this experimental setting has yet to be 
tested.  
The kinase activity of RIP-1 is dispensable for NF-B activation, but essential for 
its pro-necrosis activity (Holler et al. 2000; Lee et al. 2004; Degterev et al. 2005). RIP-1 
undergoes autophosphorylation in vitro when it is overexpressed and 
immunoprecipitated (Ting et al. 1996). The detected autophosphorylation sites of RIP-1 
all locate in its N-terminal kinase domain, which indicates a regulatory role of 
phosphorylation in RIP-1 kinase activity (Degterev et al. 2008). Besides auto-
phosphorylation, RIP-1 can also be phosphorylated by RIP-3 (Cho et al. 2009). Three 
RIP-1 kinase inhibitors have been identified: necrostatin-1 (Nec-1), necrostatin-3 and 
necrostatin-5. Necrostatin-1 allosterically inhibits the kinase activity of RIP-1 in vitro. 
Though necrostatin-3 and necrostatin-5 are structurally quite different from necrtostatin-
1, they are as potent inhibitors for immunoprecipitated RIP-1 as necrostatin-1. 
Necrostatin-3 directly inhibits RIP-1, while necrostatin-5 is likely to indirectly suppress 
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the kinase activity of RIP-1 through interacting with other components associated with 
RIP-1 in the cell (Degterev et al. 2005; Teng et al. 2005; Degterev et al. 2008).  
Some studies showed that RIP-1 is a negative regulator for apoptosis. 
Knockdown of RIP-1 in TNF--treated L929 cells switches the TRADD-independent 
necroptosis to TRADD-dependent apoptosis. This effect is RIP-1 specific, as knockdown 
of RIP-3 only protects L929 cells from TNF--induced necroptosis and does not lead to 
apoptosis (Vanlangenakker et al. 2011). Similarly, knockdown of RIP-1 sensitizes TRAIL-
resistant cell lines to apoptosis. Caspase 8-dependent cleavage of RIP-1 is observed in 
TRAIL-sensitive but not TRAIL-resistant pancreatic cancer cells (Wang et al. 2007). 
However, it has yet to be examined whether the cleavage of RIP-1 influences apoptosis 
induction or it is merely a secondary effect of highly active caspase 8 upon TRAIL 
ligation. The relationship of RIP-1 and apoptosis is further complicated by the discovery 
of “Ripoptosome”, which requires the kinase activity of RIP-1 for its formation and 
provokes either apoptosis or necroptosis in the cells (Feoktistova et al. 2011; Tenev et al. 
2011). 
The dual role of RIP-1 in both pro-survival and pro-death signaling suggests that 
RIP-1 associate with and is regulated by distinct molecules in different signaling 
pathways. Genome RNA interference screening revealed that RIP-3 is required for TNF-
-induced necroptosis in the presence of c-IAP antagonist or caspase inhibitor z-VAD-
fmk (He et al. 2009; Zhang et al. 2009). RIP-3 interacts with RIP-1 through its C-terminal 
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RHIM and phosphorylates RIP-1 (Sun et al. 2002a). Phosphorylated RIP-1 in turn 
phosphorylates RIP-3. The assembly of RIP-1-RIP-3 complex stabilizes the binding of 
RIP-1 to TNF- signaling complex II and mediates necroptosis (Cho et al. 2009). The 
acetylation of Lys 530 on RIP-1 inhibits the RIP-1/RIP-3 interaction and consequent 
necroptosis. NAD-dependent deacetylase sirtuin-2 (SIRT2) constitutively binds to RIP-3 
and deacetylates RIP-1 to permit TNF--induced necroptosis (Narayan et al. 2012).  
The interaction between RIP-1 and RIP-3 shifts the fate of the cell from 
apoptosis/survival to necroptosis. This necrosis-inducing complex may also contain 
FADD, caspase 8, c-FLIP and TRADD. As the assembly of RIP-3 containing complex is 
the critical step for necroptosis induction, it is termed “necrosome” to be distinct from 
other complexes that function in death receptor-mediated apoptosis or NF-B signaling 
(Declercq et al. 2009). The induction of necrosome by death receptors and T cell receptor 
(introduced in 1.2.3) is illustrated in Figure 3. 
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Figure 3: Necroptosis induction by TNFR1, Fas and TCR 
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Figure 3. TNFR1, Fas or TCR stimulation can induce necroptosis. TNFR1 
interaction with TNF- can lead to one of the three outcomes. The plasma membrane 
associated complex I leads to RIP-1 ubiquitination and NF-B activation. A death-
inducing complex II will be formed if c-FLIPL and c-IAPs are insufficient to prohibit its 
formation. Complex II leads to the inhibition of RIP-1 ubiquitination and activation of 
caspase 8. When caspase 8 activity is impaired, the repression on the phosphorylation of 
RIP-1 is withdrawn. Consequently, RIP-3 is recruited to the death-inducing complex and 
phosphorylated RIP-1. Phosphorylated RIP-1 and RIP-3 form the stable necrosome and 
induce necroptosis. Fas ligation leads to the formation of DISC, which subsequently 
activates caspase 8. Active caspase 8 triggers downstream apoptotic signaling and 
apoptosis. When caspase 8 activity is absent, necroptosis can be induced by necrosome. 
In T lymphocytes, caspase 8 is required for the inhibition of RIP-1-dependent 
necroptosis and activation of NF-B signaling upon TCR stimulation. All the isoforms of 
c-FLIP proteins inhibit caspase 8 activity, and c-FLIPL regulates the 
apoptosis/necroptosis-inducing complex II formation.  
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RIP-3 can mediate necrosis in the absence of RIP-1. RIP-3-mediated necrosis is 
found in TNF- treated L929 cells when both caspase 8 and RIP-1 were knocked down 
(Vanlangenakker et al. 2011). Similarly, MCMV infection leads to RIP-1-independent 
necrosis, which requires the expression of RIP-3 and DNA-dependent activator of 
interferon regulator factors (DAI, also known as ZBP1 or DLM-1) (Upton et al. 2010; 
Upton et al. 2012). 
1.2.1.3 The regulation of necroptosis 
Though necroptosis is an active cellular process, the induction of necroptosis 
generally requires the loss of inhibition to RIP-1 and/or RIP-3. Several regulators 
participate in this process. The most well studied negative regulator of necroptosis is 
caspase 8. Necroptosis can be induced upon the loss of caspase 8 activity, either through 
gene ablation or addition of pharmacological inhibitors (Vandenabeele et al. 2010). 
Caspase 8-deficient mice are embryonic lethal between E10.5 and E11.5. This defect is 
attributed to unregulated necroptosis, as crossing to Rip-3 background completely 
rescues the defective development of caspase-8 embryos. Rip-3caspase-8 mice are 
viable and can grow into fertile adults (Kaiser et al. 2011; Oberst et al. 2011).  
 Previous studies suggested that caspase 8 directly cleaves RIP-1 and RIP-3. Full 
length pro-caspase 8, instead of active p18/p10 dimer, is the functional anti-necroptotic 
molecule (Leverrier et al. 2011; Oberst et al. 2011). In HeLa cells treated with TNF- and 
cycloheximide (CHX), caspase 8 cleaves RIP-1 at Asp 324. The cleavage product, 42 kD 
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RIPc, enhances TRAFF and FADD association and apoptosis induction. The same 
cleavage of RIP-1 is also detected in anti-Fas treated Jurkat cells and TRAIL treated HeLa 
cells, though it shows no influence on FADD recruitment (Lin et al. 1999). In murine 
cells, caspase 8 cleaves RIP-1 to generate a 38kD fragment upon ribonucleic acid sensor 
RIG-I activation. The truncated form of RIP-1 functions as a dominant-negative inhibitor 
in RIG-I-induced activation of transcription factor IRF3 (Rajput et al. 2011). However, it 
has yet to be studied whether the spliced fragment of RIP-1 has an inhibitory role in 
necroptosis induction. RIP-3 is cleaved by caspase 8 at Asp328 in response to possible 
necroptosis-inducing stimuli, including TRAIL, TNF-/CHX and etoposide (Feng et al. 
2007). De-ubiquitining enzyme CYLD, a molecule required for necroptosis induction, is 
another identified substrate of caspase 8. Caspase 8 proteolytically cleaves CYLD at 
Asp215 to suppress CYLD activity in TNF- treated cells (O'Donnell et al. 2011). 
The anti-necroptotic role of c-IAPs was revealed using Smac mimetics. A number 
of small-molecular Smac mimetics were originally designed to inhibit XIAP, but later 
shown to function as c-IAP antagonist by inducing auto-ubiquitination and proteasome-
mediated degradation of c-IAPs (Gaither et al. 2007; Petersen et al. 2007; Varfolomeev et 
al. 2007; Vince et al. 2007; Bertrand et al. 2008). Upon TNF- stimulation, c-IAPs serve as 
the direct E3 ligase to catalyze poly-ubiquitination of RIP-1. Loss of c-IAP leads to the 
reduced ubiquitination of RIP-1. Deubiquitinated RIP-1 consequently disassociates from 
TAK1 and recruits caspase 8 and FADD to form the death-inducing complex II (Petersen 
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et al. 2007; Bertrand et al. 2008). This deubiquitination may be mediated by enzyme 
CYLD (Wang et al. 2008). c-IAP antagonists were also shown to sensitize cells to Fas-
induced apoptosis and necroptosis (Geserick et al. 2009). Since Fas usually only induces 
apoptosis in un-manipulated cells, it is likely that c-IAPs restrain RIP-1 kinase activity so 
necroptosis cannot be triggered. Smac mimetic BV6 primes RIP-1-dependent necroptosis 
in apoptosis resistant FADD- and caspase 8-deficient Jurkat T cells after TNF- 
treatment (Laukens et al. 2011). After TLR3 activation or genotoxin treatment, c-IAPs 
antagonists trigger the formation of a ~2MD cytosolic RIP-1-containing death-inducing 
complex, termed “Ripoptosome”, which leads to necroptosis when RIP-1 kinase activity 
is not sufficiently inhibited by c-FLIPL and caspase 8 (Feoktistova et al. 2011; Tenev et al. 
2011).  
Contradictory results were presented about the role of adaptor protein FADD in 
the regulation of necroptosis. The early studies showed that FADD is required for 
necroptosis (Holler et al. 2000; Lin et al. 2004). However, Jurkat T cells and primary T 
lymphocytes that lack functional FADD (FADD-deficient or expressing dominant 
negative FADD) are susceptible to RIP-1-dependent necroptosis (Degterev et al. 2005; 
Bell et al. 2008; Osborn et al. 2010; Lu et al. 2011). FADD-deficient keratinocytes exhibit 
RIP-3-dependent necroptosis in vivo (Bonnet et al. 2011). Fadd embryos showed 
increased level of RIP-1 and massive necrosis, which is rescued by crossing to Rip-1 
background (Zhang et al. 2011). Other RIP-1 associated proteins may also regulate its 
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pro-necroptotic activity by competitive binding. For example, NEMO binds to 
ubiquitinated RIP-1, thus restraining RIP-1 from necroptosis-inducing pathway 
(O'Donnell et al. 2012). 
1.2.1.4 Execution of necroptosis 
Multiple distinct cellular events were reported to contribute to the morphological 
features of necrosis. Whether these events are RIP-1/RIP-3-dependent remains to be 
identified (Vandenabeele et al. 2010). It is also unclear whether these necrosis-inducing 
pathways act independently or cooperate with each other to amplify the death signals. 
Among them, ROS generation by mitochondria is most frequently associated with RIP-
1/RIP-3-dependent necroptosis. ROS contributes to the execution of necroptosis in 
different setting of necroptosis induction, including treatment of viral caspase inhibitor 
B13R (Los et al. 2002), TLR3/TLR4 simulation in the presence of z-VAD-fmk (Kalai et al. 
2002; He et al. 2011), and death receptor ligation in the presence of z-VAD-fmk (Chen et 
al. 2009; He et al. 2011). ROS generated by NAPH oxidase (NOX) mediates the execution 
of RIP-1-dependent necrosis in Jurkat T cells co-cultured with amoeba Naegleria fowleri 
(Song et al. 2011). ROS scavenger antioxidant butylated hydroxyanisole (BHA), 
antioxidant acetylcysteine (NAC) and mitochondrial respiratory chain uncoupler 
(rotenone) prevent the Fas/zVAD-induced necroptosis (Chen et al. 2009). Interestingly, 
BHA treatment shifts the cell death pathway from necroptosis to apoptosis in L929 cells 
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after TLR3 stimulation in the presence of z-VAD-fmk (Kalai et al. 2002), suggesting in 
certain condition necroptosis is the “first-come” mechanism of death. 
RIP-3 induces the generation of ROS during necroptosis. Activated RIP-3 recruits 
and phosphorylates mixed lineage kinase domain-like protein (MLKL) and 
mitochondrial protein phosphatase PGAM5, two positive regulators of ROS generation 
(Wang et al. 2012; Zhao et al. 2012). The short isoform of PGAM5 activates the 
mitochondrial fission factor Drp1 by de-phosphorylating Drp1 at Ser637 site. Activated 
Drp1 induces mitochondrial fragmentation, an early step for necrosis execution (Wang 
et al. 2012). RIP-3 also directly associates with several metabolic enzymes: glycogen 
phosphorylase (PYGL), glutamate-ammonia ligase (GLUL) and glutamate 
dehydrogenase 1 (GLUD1). The activation of RYGL permits the degradation of glycogen 
as an energy source. GLUL and GLUD1 function together in the catabolism of glutamine 
or glutamate. The activation of GLUL, GLUD1 and PYGL contributes to the TNF/zVAD-
induced accumulation of ROS and necroptosis (Zhang et al. 2009).  
Loss of mitochondrial transmembrane potential is associated with RIP-1-
dependent necroptosis (Ma et al. 2005; Chen et al. 2009). The mechanism of RIP-1 or RIP-
3 stimulating mitochondrial permeability transition (MPT) needs to be identified. BH3-
only Bcl-2 family member Bmf was hypothesized as a potential regulator in death 
receptor-induced necroptosis by genome wide RNA interference screening (Hitomi et al. 
2008) The current hypothesis is that Bmf antagonizes anti-apoptotic Bcl-2 and Bcl-xL, two 
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inhibitors of the permeability transition pore complex (PTPC), to execute MPT (Golstein 
and Kroemer 2007; Galluzzi and Kroemer 2008). 
During apoptosis, the consumption of ATP is promptly ceased, as active caspases 
shut off the ATP-consuming cellular processes, such as translation, DNA repair and 
proteasome degradation (Vandenabeele et al. 2010). A dramatic drop of intracellular 
ATP concentration, on the other side, is associated with necrosis (Leist et al. 1997). 
Poly(ADP-ribose) polymerase-1 (PARP-1)-mediated ATP exhaustion contributes to the 
TNF/zVAD-induced necroptosis (Los et al. 2002). Nuclear enzyme PARP-1 directly 
executes necrosis through “PARP1-AIF loop”. DNA damages activates PARP-1 for DNA 
repair, a process that eventually depletes the cellular storage of ATP and NAD. The 
NAD depletion and/or poly(ADP-ribose) accumulation induce the relocation of 
apoptosis-inducing factor (AIF) from the mitochondrial intermembrane space to the 
nuclear compartment. Consequently, AIF executes large scale DNA fragmentation, 
which further causes PARP-1 activation and ATP depletion (Vandenabeele et al. 2010). 
Interestingly, when DNA damage is achieved by alkylating agents in mouse embryonic 
fibroblasts (MEFs), PARP-1 hyper-activation-induced necrosis requires the expression of 
RIP-1 and TRAF2, suggesting PARP-1 functions as an upstream regulator of RIP-1, at 
least in certain conditions (Xu et al. 2006).  
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1.2.2 Necroptosis in immune response  
Apoptosis is considered to be a type of “quiet death”, as the apoptotic bodies are 
promptly engulfed and ingested by surrounding phagocytes. In contrary, cells die 
through necrosis do not display “eat me” signals on their surface long enough before the 
plasma membrane rupture. Some of the endogenous components released from necrotic 
cells are damage-associated molecular patterns (DAMPs), which induce inflammation 
and promote immune response (Kono and Rock 2008). Admission of z-VAD-fmk in 
experimental mice stimulated through TLR3 or TLR4 results in increased serum 
concentration of several pro-inflammatory cytokines, such as IL-6, TNF-, MCP-1 and 
IFN-. This pro-inflammatory effect of z-VAD-fmk treatment requires the expression of 
RIP-3 and TRIF. Therefore, it is likely caused by increased necroptosis in macrophages 
(He et al. 2011). However, because systemic necrosis can be quite pathogenic, whether 
necroptosis induction is a potential therapeutic methodology remains debatable.  
Necroptosis is essential for the clearance of the viruses that induce resistance to 
apoptosis in the host cells. Vaccinia virus (VV) encodes caspase inhibitor B13R, which is 
92% identical to cowpox virus caspase inhibitor CrmA and sensitizes cells to necrotic cell 
death (Los et al. 2002). The infection of VV induces necroptosis in Jurkat cells and mouse 
fibroblasts (Li and Beg 2000; Chan et al. 2003). In vivo studies showed that RIP-1/RIP-3-
containing necrosome is specifically induced in the liver after VV infection (Cho et al. 
2009). Necroptosis is essential for the host defense against VV, as necroptosis-resistant 
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mice (Rip-3 or TNFSF1B) showed attenuated inflammation and defective clearance 
of the virus after VV infection (Chan et al. 2003; Cho et al. 2009). 
The pro-inflammatory feature of necroptosis can be detrimental for the host 
during infection. RIP-3-dependent necroptosis mediates the establishment of TNF-
induced systemic inflammatory response syndrome (SIRS). Deletion of RIP-3 or 
pretreatment with necrostatin-1 protects host against lethal SIRS induced by TNF- 
injection, while deletion of effector caspases (caspase 3 and caspase 7) or inflammatory 
inducer caspase 1 shows no impact. Moreover, Rip-3 mice show lower level of 
circulating DAMP than wild type controls do (Duprez et al. 2011). These results suggest 
that RIP-1 and RIP-3 are potential therapeutic targets for the treatment of systemic 
inflammation.  
Conversely, some studies suggested that programmed necrotic cells could be 
anti-inflammatory. For example, Jurkat T cells display phosphatidylserine (PS) on their 
surface when necrosis is induced by ATP depletion. Those necrotic Jurkat cells are 
preferentially engulfed by macrophages when mixed with apoptotic Jurkat T cells 
(induced by staurosporine). More importantly, those necrotic cells are capable of 
suppressing the cytokine production of macrophages, similar to apoptotic Jurkat T cells 
(Hirt and Leist 2003). Necroptotic L929 cells induced by TNF-are shown to be anti-
inflammatory when co-cultured with macrophages. Macrophages engulf the cellular 
particles of necrotic cells after they loss the plasma membrane integrity, while apoptotic 
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bodies are internalized as a whole. Nevertheless, neither apoptotic nor necrotic L929 
cells induce pro-inflammatory cytokine production in this experimental setting 
(Brouckaert et al. 2004). Whether those studies truly reflect the innate immune response 
in vivo is debatable. The cell type of the apoptotic/necrotic cells may also determine 
whether the cell death is pro-inflammatory.  
Some pathogens evolved to manipulate necroptosis to escape the attack from 
immune system. Murine cytomegalovirus (MCMV) infection induces RIP-3-dependent, 
but RIP-1-independent necrosis. One strain of MCMV, viral M45, encodes the inhibitor 
of RIP-3, which attenuates inflammation to avoid consequent virus clearance (Upton et 
al. 2010). On the other side, some pathogens actively induce necroptosis for efficient 
invasion. Naegleria fowleri, the free-living amoeba that causes primary amoebic 
meningoencephalitis in human, damages host tissues through lytic necrosis. Co-
incubation of N. fowleri and Jurkat T cells results in RIP-1-dependent necroptosis in 
Jurkat T cells (Song et al. 2011).  
1.2.3 Necroptosis in T lymphocytes 
T lymphocyte was one of the first type of cells in which necroptosis was 
identified. In 2000, Holler et al. reported that Fas ligation induces RIP-1-dependent cell 
death when caspase activities are ablated by pan-caspase inhibitor z-VAD-fmk (Holler et 
al. 2000). Later, necroptosis were identified by several genetically modified T cell 
models. Caspase 8-deficient T cells fail to undergo clonal expansion due to excessive 
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TCR activation-induced cell death (Salmena et al. 2003), which is mediated RIP-3-
dependent necroptosis (Ch'en et al. 2011). Adapter protein FADD is also involved in the 
suppression of necroptosis in T lymphocytes. T cells that lack FADD or express 
dominant-negative FADD (tFADDdd) showed RIP-1 kinase activity-dependent cell 
death upon TCR stimulation (Bell et al. 2008; Osborn et al. 2010).  
The mechanism of TCR activation-induced necroptosis in T lymphocytes is not 
well studied. It is likely to utilize the similar pathways as death receptor and TLR-
induced necroptosis (Figure 3). The catalytic activity of pro-caspase 8 suppresses 
necroptosis (Leverrier et al. 2011), while RIP-1 and RIP-3 are required for necroptosis 
induction in activated T cells (Ch'en et al. 2011a; Lu et al. 2011). RIP-1 phosphorylation is 
shown in necroptotic FADD-deficient T lymphocytes by western blot. However, neither 
phosphorylation of RIP-3 or RIP-1/RIP-3 complex is detected in this system (Osborn et 
al. 2010). It is unclear whether these results are caused by the limitation of methodology 
and experimental setting, or necroptosis in T lymphocytes does not require the kinase 
activity of RIP-3. Nevertheless, the expression of RIP-3 is the requisite factor for 
necroptosis in T cells, as crossing to Rip-3 mice rescues the defective proliferation and 
necroptosis phenotype in tFADDdd mice (Lu et al. 2011). 
The significance of TCR activation-induced necroptosis for T cell homeostasis is 
unclear. One possible explanation is that activated T cells resistant to death receptor 
mediated apoptosis need to be removed to protect the host from sever autoimmunity. 
  42 
The phenotype of T cell-specific deletion of caspase 8 (tCasp8) supports this theory to a 
degree. Though caspase 8-deficient T cells are resistant to Fas-induced apoptosis, 
tCasp8mice do not accumulate double-negative T cells in the blood and lymphoid 
organs, or develop the SLE-like autoimmune phenotype as lpr/lpr mice (Salmena and 
Hakem 2005). It is probably because activated caspase 8-deficient T cells are eliminated 
by necroptosis. Rip-3tcasp8 and Rip-3tFADDdd mice show lymphoproliferative 
syndrome reminiscent of lpr/lpr mice (Ch'en et al. 2011a; Lu et al. 2011), as activated 
peripheral T cells cannot be cleared. The reporters did not address whether SLE-like 
autoimmunity was developed in those mice, which will be interesting to examine in the 
future study. On the other side, the protective effect of necroptosis seems to be 
insufficient with age, as tcasp8mice eventually develop lethal age-related 
lymphoproliferative disease (Salmena and Hakem 2005). 
 1.3 Macroautophagy in T lymphocytes 
This section is adapted from “Macroautophagy in T lymphocyte development ad 
function”. Ming-Xiao He et al., Frontiers in Immunology, 2012;3:22. doi: 10.3389/ 
fimmu.2012.00022. 
Autophagy is a cellular process characterized by the sequestration of cytoplasmic 
compartments through double-membrane vacuoles, termed autophagosomes. Based on 
the mechanism by which cargo is delivered for degradation, autophagy is subdivided 
into three types: macroautophagy, microautophagy and chaperone-mediated 
autophagy. Microautophagy is characterized by the direct sequestration of cytosolic 
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component into lysosomes by invagination or arm-like protrusion of lysosomal 
membrane. The physiological role of microautophagy in mammalian cells is yet 
unrevealed, as the approaches to detect this process are limited (Mijaljica et al. 2011). 
Chaperone-mediated autophagy (CMA) is a highly regulated process, in which cytosolic 
proteins are sorted one-by-one by the heat shock cognate protein 70 (Hsc70) into 
lysosomes (Kaushik and Cuervo 2012). Among the three types of autophagy, 
macroautophagy is the most studied in mammalian cells. Macroautophagy has been 
shown to be essential for providing nutrients during starvation, clearing long-lived 
proteins as well as unwanted organelles, and fighting intracellular infections in multiple 
types of mammalian cells (Mortimore and Poso 1987; Levine et al. 2011).  
1.3.1 Mechanism of macroautophagy 
Macroautophagy (thereafter referred as autophagy) starts with the generation of 
double-membrane structures termed isolation membranes or phagophores. The 
phagophore sequestrates intracellular components to form the intracellular double-
membrane autophagosomes. Consequentially, autophagosomes fuse with lysosomes 
and the inside content is digested (Klionsky and Emr 2000). The biogenesis of 
autophagosomes requires a group of evolutionarily conserved genes, referred to as 
autophagy-related genes (Atgs) (Longatti and Tooze 2009). The initiation of the 
phagophore requires the class III phosphatidylinositol 3-kinase (PtdINs3K) complex, 
which further activates two ubiquitin-like conjugation systems: The Atg12-Atg5 
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conjugation and LC3-processing (Ohsumi and Mizushima 2004; Pua and He 2009b). For 
Atg12-Atg5 conjugation, Atg12 is first linked to Atg7 (E1), then to Atg10 (E2). Atg10 is 
subsequently replaced by Atg5 (E3) to form the Atg12-Atg5 conjugate. LC3 processing 
starts with the association between the inactive form of LC3, LC3-I, with activated Atg7 
(E1). Atg3 (E2) then exchanges Atg7, and catalyzes the addition of a hydrophobic 
phosphatidylethanolamine (PE) tail to LC3. These reactions transform the inactive LC3-I 
is to the active LC3-II. Atg12-Atg5 conjugates and LC3-II insert into the intracellular 
membrane, leading to the formation of the isolation membrane/phagophore. While both 
systems are required for autophagy, the Atg12-Atg5 conjugate assembles on 
phagophore prior to the insertion of LC3, and contributes to LC3 processing (Hailey et 
al. 2010; Levine et al. 2011). 
In the immune system, autophagy balances the threshold of immune responses 
to protect against infection, autoimmunity and inflammatory diseases (Levine et al. 
2011). The primary role of autophagy in cells depends on the cell type and environment. 
To study the role of autophagy in primary T lymphocytes, several specific knockout or 
transgenic models have been developed during the past few years, and it has been 
revealed that autophagy plays a crucial role in T cell homeostasis and proper T cell 
response. The phenotypes of different Atg-deficient T lymphocytes showed a great deal 
of similarity, with certain differences, which can be explained as a result of different 
deletion efficiency, accumulating effects, or the molecular functions independent of 
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autophagy. From here I will review the current findings concerning how autophagy 
regulates the survival and function of T cells, and compare different model to show the 
role of autophagy, not each individual Atgs, in T lymphocytes.  
1.3.2 Autophagy induction in T lymphocytes 
Although relatively low, autophagy can be detected in all subsets of thymocytes 
and freshly isolated naïve T cells (Lu et al. 2006; Pua et al. 2007; Stephenson et al. 2009). 
These results were fairly surprising, since T cells contain limited cytoplasm. The 
existence of autophagy in T lymphocytes suggests that autophagy may play a regulatory 
role in T cells. Aging T lymphocytes, on the other hand, shows an accumulation of 
autophagic vacuoles. In a study of long term in vitro human lymphocyte culture, the 
percentage of cells with autophagosomes increased during culture, which was 
associated with the increase in lysosomal mass and accumulation of lipofusion events. 
(Gerland et al. 2004). 
T lymphocytes display TCR activation-induced autophagy (Pua et al. 2007; Pua 
et al. 2009; Hubbard et al. 2010; Jia and He 2011; Jia et al. 2011; Kovacs et al. 2011). CD4 
T cells upregulate Beclin-1 (Atg6) and LC3 (Atg8) upon TCR stimulation (Arsov et al. 
2008). Ultrastructural studies revealed an increase in the number and a decrease in the 
size of autophagosomes after TCR stimulation. Interestingly, while mitochondria are 
frequently contained in the autophagosomes of resting T cells, the autophagic cargo 
switches to almost exclusively cytosolic material in activated T cells (Hubbard et al. 
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2010). Mitochondria undergo morphological changes during autophagy induction to 
escape autophagic degradation and maintain energy production in MEFs (Gomes et al. 
2011). It is worth to investigate whether T lymphocytes apply similar strategies or 
utilizes unique pathways to regulate the mitochondrial content.  
TCR-induced autophagy requires the key autophagy machinery, as deleting 
Atg5, Atg7, or Atg3 abolishes autophagosomal induction (Pua et al. 2007; Pua et al. 2009; 
Hubbard et al. 2010; Jia and He 2011). JNK1/JNK2 is required for TCR-induced 
autophagy in CD4 T cells (Lu et al. 2006). Beclin-1, a component of PtdINs3K complex, 
was shown to be crucial for autophagy initiation (Yue et al. 2003). Nevertheless, 
overexpression of Beclin-1 in T lymphocytes by a bacteria artificial chromosome (BAC) 
transgene did not change the basal level of autophagy in multiple organs including 
thymus and spleen (Arsov et al. 2008). Contradictory results were presented regarding 
the role of class III PI3K, Vps34, in the autophagy induction in T lymphocytes. One 
study, in which the ATP binding region of Vps34 was deleted to generate a truncated 
protein, suggested that Vps34 was dispensable for autophagy induction in mature T 
lymphocytes (McLeod et al. 2011). However, complete deletion of Vps34 impairs 
autophagy induction (Willinger and Flavell 2012). It is possible that the kinase activity of 
Vps34 is not required for autophagy as least in mature T lymphocytes. The autophagy 
machinery in T lymphocytes is illustrated in Figure 5. 
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Figure 4: Macroautophagy induction in T lymphocytes 
Figure 4. TCR engagement is a strong inducer for autophagy in primary T cells. 
Autophagy is induced by the PtdIns3k complex in many types of cells, but the role of 
Beclin-1/Vps34 in autophagy induction in T lymphocytes is controversial. The two 
autophagosome processing pathways: Atg12-Atg5 conjugation and LC3 processing are 
essential for autophagy induction in T lymphocytes. Furthermore, FADD, the death 
adaptor protein in the extrinsic death pathway, may play a key role in mediating a 
crosstalk between the apoptosis and autophagy pathways. 
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 TCR-induced autophagy is compromised in aged CD4 T cells (Mattoo et al. 
2009). The mechanism by which autophagy is defective during aging is unclear. Some 
evidence suggests that the Rel family member, p65, may be involved. The nuclear 
translocation of p65 upon TCR signaling is impaired in aged CD4 T cells (Mattoo et al. 
2009), and p65 has been shown to activate autophagy by upregulating the transcription 
of Beclin-1 in multiple cell lines (Copetti et al. 2009). It is yet unknown whether defective 
autophagy induction leads to other defects in aged T lymphocytes, such as increased 
mitochondrial damage, reduction in glycolysis, or enhanced apoptosis upon primary 
TCR stimulation.  
1.3.3 Autophagy in T lymphocyte homeostasis: different genetic 
models, similar defects 
Several tissue specific knockout models have been developed during the past 
few years to study the role of autophagy in T lymphocytes. The deficiency in autophagy-
related genes leads to a blockage in autophagic flux, as well as impaired T cell 
homeostasis. In Atg5 fetal liver chimeric mice, the thymocytes undergo full 
maturation, but the thymic cellularity is reduced by half. The number of peripheral T 
lymphocytes is also decreased, which is likely attributed to both the loss of thymocytes 
and increased cell death rate (Pua et al. 2007). The Atg5f/f Lck-Cre mice generated later 
showed an almost identical phenotype to the Atg5 chimera (Stephenson et al. 2009). 
The debate remains as to whether the enhanced cell death is caused by loss of 
autophagy, but not specific functions of Atg5. Atg5 is certainly involved in apoptosis 
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pathway. Overexpression of Atg5 increases the apoptotic rate in HeLa cells, a phenotype 
dependent on FADD. Antisense cDNA knockdown of FADD protects HeLa cells from 
Atg5-induced apoptosis, whereas autophagy is still upregulated in Atg5 overexpressing 
cells (Pyo et al. 2005). Atg5 also sensitize cell to apoptosis in a FADD-independent 
pathway. The truncated form of Atg5 antagonizes Bcl-xL to enhance MOMP and 
cytochrome c release (Yousefi et al. 2006). Therefore, Atg5 may regulate apoptosis in 
extrinsic and intrinsic apoptosis pathways. 
To address whether autophagy indeed regulates T cell homeostasis, several other 
tissue specific knockout models have been analyzed. Mice with tissue specific deletion of 
Atg3 in T lymphocytes by Lck-Cre system (deletion occurs during double negative stage 
in thymus) show an almost identical phenotype as the Atg5 chimera, characterized by 
normal frequencies of DN, DP, and SP thymocytes in the thymus, but a reduced 
cellularity in both the thymus and peripheral T cell pools (Jia and He 2011). On the other 
side, the thymocyte cellularity in Atg7f/f Lck-Cre mice is barely decreased (Stephenson et 
al. 2009), with only a minor reduction in SP cells. No thymocyte defect was reported in 
the BECNf/f CD4-Cre, Vps34f/f CD4-Cre models (Kovacs et al. 2011; Willinger and Flavell 
2012). Despite the difference inside the thymus, T lymphocytes in all these models 
(Atg5 chimera, Atg5f/f Lck-Cre, Atg7f/f Lck-Cre, Atg3f/f Lck-Cre, BECNf/f CD4-Cre and 
Vps34f/f CD4-Cre) show decreased cellularity in the periphery and an enhanced 
apoptosis rate (Pua et al. 2007; Pua et al. 2009; Stephenson et al. 2009; Jia and He 2011; 
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Kovacs et al. 2011). There are several explanations for the difference of the thymocyte 
phenotypes in these autophagy-deficient T cell models. First of all, different T cell-
specific deletion strategies were applied in these studies. The deletion of Beclin-1 and 
Vps34 was driven by CD4-Cre, which is expressed at DP stage. Therefore, the deletion in 
the CD4-Cre models may occur much later than that in the Lck-Cre models. Autophagy 
may be required at DN-DP stage for thymocyte development, but dispensable beyond 
DP stage. The second possibility is that the defect in thymocytes is accumulated and 
requires a relative long time of autophagy inhibition. As a result, the CD4-Cre models, in 
which deletion occurs at a later developmental stage, showed milder defect than the 
Lck-Cre models. Additionally, low deletion efficiency in CD4-Cre model may cause the 
differences, as enough protein may be left for autophagy induction. Finally, some other 
effectors may replace PtdIns3k complex for autophagy induction in thymocytes, so 
Beclin-1 and Vps34 are dispensable for autophagy induction in thymocytes.  
Ortiz’s group utilized a Rag1 (recombination activating gene-1 null) blastocyte 
complementation to study the role of Beclin-1 in hematopoietic cells. Beclin-1 deficient 
(BECN) blastocytes were transferred to a Rag-1 host in this study. The data showed 
that Beclin-1 is required for the maintenance of early thymocyte progenitors. 
Controversially, survival and TCR-induced proliferation remains normal in BECN T 
lymphocytes developed in this system. Moreover, autophagy can be detected in those 
cells, though decreased compared to controls (Arsov et al. 2011). These results indicate 
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that a Beclin-1-independent autophagy-inducing pathway may occur in T lymphocytes. 
The mechanism of autophagy induction in the absence of Beclin-1 needs to be 
determined. 
1.3.4 Autophagy in T cell function 
1.3.4.1 Autophagy and intracellular organelle homeostasis 
Autophagy plays a role in controlling mitochondria during T cell development 
(Pua et al. 2009; Stephenson et al. 2009). Transcriptional profiling of Atg5-deficient T 
lymphocytes shows a remarkable enrichment in mitochondrion-associated genes 
(Stephenson et al. 2009). The mitochondrial content in T lymphocytes gradually 
decreases during the transition from thymocytes to peripheral T lymphocytes. The level 
of mitochondria is the highest in DP thymocytes, followed by SP thymocytes, and 
mature T lymphocytes contain the lowest volume (Pua et al. 2009). This contraction of 
mitochondria requires autophagy, as least partially, as mitochondrial content is higher 
in Atg5, Atg7 and Atg3 T lymphocytes than that in wild-type T lymphocytes (Pua 
et al. 2009; Stephenson et al. 2009; Jia et al. 2011). Conversely, it was reported that cells 
from BECNf/f CD4-Cre mice showed no change in mitochondrial content (Kovacs et al. 
2011). One possible explanation is that genomic deletion only starts in DP thymocytes in 
this model, and persistent levels of Beclin-1 protein in cells is enough to mediate the 
autophagic degradation of mitochondria. Still, we cannot rule out the possibility that 
controlling mitochondrial content is achieved independent of Beclin-1. Nevertheless, 
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current data suggests that autophagy protects T lymphocytes during the migration from 
thymus to the periphery by eliminating excessive mitochondria. Mitochondria are 
believed to be the major reservoir of toxic ROS in cells (Hildeman et al. 2003). The 
oxidative tension is much higher in the blood than in the thymus (Braun et al. 2001; 
Sitkovsky and Lukashev 2005). Therefore, maintaining the same level of mitochondria in 
peripheral T cells as in thymocytes can cause intolerable levels of ROS. 
Endoplasmic reticulum (ER) is well regulated by autophagy. An increase in ER 
volume can be observed in autophagy-deficient T lymphocytes (Jia et al. 2011). Different 
from mitochondria, ER volume is downregulated in the transition of DN to DP 
thymocytes, and maintained to a similar level afterwards. The accumulation of ER, as 
well as mitochondria, requires a long period of time to establish (up to 18 days in vitro) 
after autophagy is abolished by inducible-deletion in mature T lymphocytes. 
Interestingly, lymphocytes did not show elevated cell death until 24 days after inducible 
deletion of Atg3. These data suggest that the elevated cell death in autophagy-deficient 
T lymphocytes is possibly the outcome of cellular organelles’ abnormality. 
1.3.4.2 Autophagy in T cell activation 
Different groups have identified that autophagy-related genes are required for T 
cell proliferation upon TCR stimulation. T lymphocytes lacking Atg5, Atg7, Atg3, or 
Beclin-1 all show impaired TCR stimulation-induced proliferation (Pua et al. 2007; Pua 
et al. 2009; Stephenson et al. 2009; Hubbard et al. 2010; Jia et al. 2011; Kovacs et al. 2011). 
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Severe TCR stimulation-induced cell death is observed in Beclin-1-deficient lymphocytes 
(Kovacs et al. 2011). The survival defect may contribute to impaired proliferation in 
autophagy-deficient T lymphocytes. Meanwhile, autophagy is required for intact TCR 
signal by maintaining intracellular organelle homeostasis. Atg7 T cells displayed 
impaired calcium influx upon TCR stimulation, as well as increased calcium efflux from 
ER to cytosol. The excessive ER in those cells leads to abnormal redistribution of calcium 
into the ER upon TCR stimulation (Jia et al. 2011). Besides the calcium signal, other TCR 
signal components such as PLCγ-1 (the upstream signal of calcium efflux), p38, ERK, 
and NF-κB activation all remain unchanged in Atg7-deficient T lymphocytes (Jia et al. 
2011). 
Autophagy is involved in the metabolism of activated T lymphocytes. Upon TCR 
activation, T lymphocytes undergo a metabolic switch and produce more ATP to ensure 
sufficient energy for protein synthesis, cytokine secretion, and cellular division (Fox et 
al. 2005). Without autophagy, the ATP production in activated T lymphocytes is reduced 
to resting levels. The lack of ATP, at least partially, contributes to impaired transcription 
and production of IFN-γ and IL-2 in those cells, as methyl pyruvate, a cell-permeable 
intermediate of glucose, incompletely rescues both ATP generation and cytokine 
production (Hubbard et al. 2010). However, another study showed of IL-2 secretion is 
increased in autophagy-deficient T lymphocytes after TCR activation (Jia et al. 2011). 
This controversy may be the consequence of the autocrine nature of IL-2: IL-2 is 
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consistently produced and utilized by activated T lymphocytes (Cantrell et al. 1988). 
Therefore, the IL-2 detected in culture medium at a single time point may or may not 
reflect the capacity of IL-2 production. To settle the debate, careful study in the kinetics 
of the transcription and secretion of cytokines is needed.  
Autophagy is differentially regulated in T helper subsets. T lymphocytes 
cultured in TH2 polarizing condition in vitro contain more autophagosomes than those 
cultured in TH1 polarizing conditions (Lu et al. 2006). TH17 cells are relatively more 
resistant to cell death in the absence of Beclin-1, compared to TH0, TH1, and TH2 cells 
(Kovacs et al. 2011). TH17 cells, along with TH1 cells, mediate the pathogenesis of 
experimental autoimmune encephalomyelitis (EAE) (El-behi et al. 2010). Though TH17 
cells manage to survive when autophagy is blocked, mice with Beclin-1-deficient T 
lymphocytes still showed resistance to EAE development. The number of MOG specific 
TH1 and TH17 cells are reduced in the periphery and undetectable in the central nerve 
system (CNS) in the T cell specific Beclin-1-deficient mice (Kovacs et al. 2011). The 
protective role of Beclin-1-deficient T lymphocytes in EAE induction may be the result of 
defective antigen-induced proliferation. 
1.3.5 Autophagy in HIV infection 
Autophagy is involved in the progressive decline in the number of CD4 T cells 
during human immunodeficiency virus infection/acquired immunodeficiency syndrome 
(HIV/AIDS). HIV infection induces cell death in both infected and uninfected 
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“bystander” CD4 T cells (Laurent-Crawford et al. 1993). HIV-1 envelope glycoproteins 
(Env), composed of gp41 and gp120 subunits, is expressed on infected human 
lymphocytes. Via CXCR4 and CCR5, Env triggers autophagy in uninfected “bystander” 
CD4 T cells, which eventually leads to apoptosis in those cells (Espert et al. 2006; Espert 
et al. 2009). The gp41 fusion to target membranes is required for Env-mediated 
autophagy (Denizot et al. 2008). Interestingly, autophagy is repressed in infected CD4 T 
cells (Zhou and Spector 2008). The effect of killing surrendering T cells through surface 
protein Env seems to be T cell specific, as Env expressed on macrophages with CXCR4 
and CCR5 fails to induce autophagy in uninfected CD4 T cells in a co-culture 
experiment (Espert et al. 2009). From the perspective of virus, downregulation of 
autophagy in host cells may be beneficial, as autophagy potently attacks virus through 
xenophagic degradation and facilitates antigen presentation (Kim et al. 2010). At the 
same time, provoking excessive autophagy in uninfected surrounding lymphocytes 
promotes cell death, further weakening the host defense by reducing potential adaptive 
immunity against the virus. 
In conclusion, autophagy is required for the homeostasis and function of T 
lymphocytes. Deletion of different autophagy-related genes results in similar 
phenotypes in T lymphocytes, indicating the defects are caused by a loss of autophagy 
instead of other functions of those proteins. T lymphocytes utilize autophagy to 
maintain intracellular organelle homeostasis, intact TCR signaling, and metabolic switch 
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upon TCR activation. Identifying new players in the regulation of autophagy in T 
lymphocytes will broaden our understanding in the role of autophagy in T cell 
homeostasis. 
1.4 The interplay of apoptosis, necroptosis and autophagy in T 
lymphocytes 
1.4.1 The interplay of autophagy and apoptosis in T lymphocytes 
As mentioned before, the loss of autophagy-related genes generally leads to 
increased cell death (Pua et al. 2007; Pua et al. 2009; Stephenson et al. 2009; Jia et al. 
2011). The crosstalk between autophagy and apoptosis has been observed in various 
eukaryotic cells (Thorburn 2008), but how autophagy regulates apoptosis in T 
lymphocytes remains unclear. Atg7-deficient T lymphocytes upregulate the expression 
of Bcl-2, but the expression levels of other pro-apoptotic or anti-apoptotic proteins are 
unchanged in the absence of Atg7 (Pua et al. 2009). Beclin-1-deficient T lymphocytes 
show highly increased protein levels, but not mRNA levels of pro-apoptotic pro-caspase 
8, pro-caspase 3, and Bim, which suggests a block in the post-translational regulation of 
these proteins (Kovacs et al. 2011). Caspase 8 is detected in p62/ubiquitin-containing 
aggregates in BECN T cells (Kovacs et al. 2011). It is reasonable to hypothesize that p62 
targets caspase 8 for autophagic degradation. However, that hypothesis is condemned 
by the fact that pro-caspase 8 level is comparable between wild-type and p62-deficient T 
cells. Further studies are required to identify whether Beclin-1 controls pro-apoptotic 
protein levels through Bcl-2 binding, autophagy induction, or other pathways. 
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Though autophagy is required for survival, excessive autophagy seems to be 
destructive for T lymphocytes. Autophagy promotes, rather than protects, growth factor 
withdrawal-induced cell death in a TH2 cell line (Lu et al. 2006). In long-term human 
CD8 T cell cultures, cells with higher numbers of autophagosomes died out first 
(Gerland et al. 2004). However, it is still unclear whether the high number of 
autophagosomes reflects an increase in flux or a blockage of autophagosome–lysosome 
fusion. Whether those cells undergo enhanced autophagy remains to be verified. When 
exposed to IFN-γ, Irgm 1 (Interferon-γ inducible, immunity-related GTPase) T cells 
showed greatly enhanced death in an autophagy-dependent manner (Feng et al. 2008). 
Ginsenoside Re suppresses autophagy by inhibiting Irgm 1 and IFN-γ production in 
human T lymphocytes, which leads to enhanced proliferation and reduced cell death 
(Son et al. 2010).  
1.4.2 The interplay of autophagy and necroptosis in T lymphocytes 
Necroptosis and enhanced autophagy were observed in the same population of 
cells when caspase 8 activity was blocked (Yu et al. 2004; Degterev et al. 2005; Lu et al. 
2006; Wu et al. 2011). Whether autophagy contributes to necroptosis in T lymphocytes is 
debatable. FADD is required for death receptor-mediated caspase 8 activation (Zhang et 
al. 1998). Similar to caspase 8-deficient T cells, T cells lacking FADD die through TCR 
activation-induced necroptosis. TCR-induced necroptosis in Fadd and caspase-8 T 
cells is independent of autophagy (Osborn et al. 2010; Ch'en et al. 2011). However, 
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hyperactive autophagy seems to be involved in the RIP-1-dependent necroptosis in T 
cells expressing a dominant-negative FADD (FADDdd). Inhibition of autophagy with 3-
methyladenine (3-MA), dominant-negative Vps34 or silencing of Atg7 rescued the cell 
death phenotype in FADDdd T cells (Bell et al. 2008). Autophagy-dependent cell death in 
FADDdd T cells may be attributed to the specific cellular function of the dominant-
negative FADD instead of the loss of FADD function. FADD and caspase 8 associate 
with Atg12-Atg5 conjugates, the essential molecule complex for autophagy induction 
(Bell et al. 2008). Therefore, the mutated FADD may modulate the autophagy 
machinery. 
Studies in other type of cells also provided controversial results in the 
relationship between necroptosis and autophagy. While some studies show that 
autophagy contributes to the induction of necroptosis, other studies show opposite 
results (Yu et al. 2004; Bell et al. 2008; Osborn et al. 2010; Ch'en et al. 2011b; Chen et al. 
2011). Necroptosis is usually associated with increased ROS production and 
dysfunctional mitochondria, so the enhanced autophagy may be a desperate survival 
attempt by the cell to clean damaged organelles. In some studies, attenuation of 
autophagy by siRNA knockdown benefited the cells, while thoroughly abolishing 
autophagy may create additional stress, thus killing instead of protecting the cells. 
Careful analyses of cell death pathways in necroptotic T cells, especially with modest 
inhibition of autophagy, will provide us valuable information to understand the 
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relationship between autophagy and necroptosis. Altogether, autophagy is shown to 
play a dual role in T lymphocytes: autophagy is critical for cell survival and T cell 
response, while too many autophagic vacuoles may create intolerable stress. 
1.5 The role of c-FLIP in T lymphocytes 
1.5.1 c-FLIP proteins 
Cellular caspase 8 (FLICE)-like inhibitory protein (c-FLIP), also known as CASP8 
and FADD-like apoptosis regulator (CFLAR), is a homologue and negative regulator of 
caspase 8. c-FLIP was cloned by several groups back to 1997, when it was given several 
names including CLARP, FLAME, I-FLICE, MRIT, Usurpin, Casper, and CASH (Goltsev 
et al. 1997; Han et al. 1997; Hu et al. 1997; Irmler et al. 1997; Shu et al. 1997; Srinivasula et 
al. 1997; Rasper et al. 1998). c-Flip gene locates upstream of caspase 10 and caspase 8 
gene in human genome and only 40kb away from caspase 8 gene in mouse genome. The 
genomic location and structure suggest a gene-duplication event during the evolution. 
Multiple splice variants of c-Flip gene have been reported. In mammalian cells, three 
isoforms of c-FLIP protein have been identified: 24 kD c-FLIPR, 26kD c-FLIPS and 55kD 
c-FLIPL (Irmler et al. 1997; Rasper et al. 1998; Golks et al. 2005). Only c-FLIPR and c-FLIPL 
are expressed in murine cells. Like caspase 8, all c-FLIP proteins contain two DED 
domains. c-FLIPL also shows distinct homology to the protease region of caspase 8 at the 
C-terminal (Goltsev et al. 1997). However, it lacks the conserved caspase active residues, 
including the cysteine residue within the Gln-Ala-Cys-X-Gly motif and the histidine 
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residue within the His-Gly motif (Cohen 1997). Interestingly, retro-mutation of these 
residues back to their functional counterparts (in caspase 8) is not sufficient to restore 
the proteolytic activity, which suggests other inhibitory elements are within c-FLIP 
protein (Rasper et al. 1998). c-FLIPR and c-FLIPS contain short C-terminus and lack the 
catalytic sites for caspases (Golks et al. 2005; Poukkula et al. 2005). Therefore, they are 
resistant to cysteine protease cleavage (Figure 5A).  
All three isoforms of c-FLIP are degraded through the ubiquitin-proteasome 
pathway. However, the half-lives of c-FLIPS and c-FLIPR are shorter than that of c-FLIPL 
(Poukkula et al. 2005; Kaunisto et al. 2009). The ubiquitination and rapid turnover of c-
FLIPS is dependent on its specific 19 amino acid C-terminal tail, in which Lys192 and 
Lys195 are ubiquitinated (Poukkula et al. 2005). c-FLIPR contains Lys195 but not Lys192, 
and it is regulated in a similar pattern as c-FLIPS (Golks et al. 2005). The in vivo 
phosphorylation of the conserved S193 is critical for the ubiquitination of all three 
isoforms. While the ubiquitination leads to fast degradation of c-FLIPS and c-FLIPR, it 
surprisingly does not affect the stability of c-FLIPL (Kaunisto et al. 2009). Cellular ROS 
stimulates ubiquitination on c-FLIPL at Lys167, which consequently leads to the 
degradation of c-FLIPL by the proteasome. Phosphorylation at the Thr166 residue is also 
required for ROS-induced ubiquitination and degradation of c-FLIPL (Wilkie-Grantham 
et al. 2013).  
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Figure 5: The structure of c-FLIP proteins. 
Figure 5. (A) Schematic structure of c-FLIPL, c-FLIPS and c-FLIPR. All c-FLIP 
proteins and caspase 8 contain two DEDs on the N-terminus. c-FLIPL contains a 
caspases-like domain in the C-terminal region, which shares homology with caspases 8. 
(B) Processing of c-FLIPL by caspase 8. c-FLIPL-caspase 8 interaction leads to incomplete 
cleavage of caspase 8 and c-FLIPL.  
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1.5.2 c-FLIP in the regulation of apoptosis  
c-FLIP is originally identified as an anti-apoptotic protein. Down-regulation of c-
FLIP in cultured leukemic T cells is correlated with the increased sensitivity to Fas-
induced apoptosis (Peter et al. 1997). c-FLIP associates with adaptor protein FADD, pro-
caspase 8 and pro-caspase 10 via its two DEDs, whereas it lacks the proteolytic activity 
of caspases. This competitive heterodimerization blocks pro-caspse8/10 recruitment to 
DISC by adaptor protein FADD, thus inhibiting Fas(CD95)- and TNFR1-induced 
apoptosis (Goltsev et al. 1997; Han et al. 1997; Hu et al. 1997; Irmler et al. 1997; Shu et al. 
1997; Srinivasula et al. 1997; Rasper et al. 1998). The recruitment of c-FLIP protein to 
DISC and its anti-apoptotic activity is not affected by its ubiquitination (Poukkula et al. 
2005; Kaunisto et al. 2009). c-FLIPL, as well as its C-terminal p12 domain alone, also 
directly interacts with the death domain of DR5 to prevent the recruitment of FADD and 
the formation of a functional DISC (Jin et al. 2004). However, overexpression of c-FLIPL 
in certain cell lines does not promote survival but increase apoptosis (Inohara et al. 1997; 
Shu et al. 1997; Micheau et al. 2002). The mechanism of this phenotype is dubious, but it 
is someway caspase 8-dependent. As caspase 10 is the homologue of caspase 8 and only 
expressed in human, from here I will focus on the knowledge gained from animal study 
regarding the relationship of c-FLIP and caspase 8. 
The structure of c-FLIP proteins lead to the difference in their function. c-FLIPL, 
c-FLIPR and c-FLIPS all compete with pro-caspase 8 for association with FADD and pro-
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caspase 8 itself. However, c-FLIPL interacts with pro-caspase 8 via both two DEDs and 
caspase-like C terminus, which leads to the complexity of the function of c-FLIPL. The 
pro-caspase 8-c-FLIPL heterodimer exhibits proteolytic activity. As a consequence, 
partial auto-processed caspase 8, p43 fragments of caspase 8, is generated (Micheau et al. 
2002). c-FLIPL is also cleaved by caspase 8 to generate the N-terminal p43FLIP and the C-
terminal p12 fragment (Figure 5B). c-FLIPL and p43cFLIP recruit TRAF2 and RIP-1 to 
DISC, which subsequently activate pro-survival NF-B signaling (Shu et al. 1997; 
Kataoka and Tschopp 2004; Dohrman et al. 2005a; Budd et al. 2006). The RIP-1 
recruitment may also contribute to the c-FLIPL-caspase 8 inhibition on necroptosis 
(Oberst et al. 2011) (will be introduced in the next section). In contrast, due to the lack of 
pro-caspase 8-like C-terminal domains, c-FLIPR and c-FLIPS solely functions as 
competitors for caspase 8 recruitment and homodimerization.  
Overexpression of c-FLIPL increase the rate of apoptosis in some cell lines and T 
lymphocytes (Inohara et al. 1997; Shu et al. 1997; Dohrman et al. 2005b). This phenotype 
was explained by the mechanism that c-FLIPL-caspase 8 heterodimer augments caspase 
activity to execute apoptosis. However, biochemistry data is lacked to show the 
mechanism of effector caspase activation by c-FLIPL-caspase 8 heterodimer. The other 
question needing to be answered is whether physiological expression level of c-FLIPL is 
ever sufficient for this effect. 
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1.5.3 c-FLIP in the regulation of necroptosis  
Recent study suggested that the long isoform of c-FLIP contributes to the 
suppression of necroptosis. Caspase 8 negatively regulates RIP-1 activity by cleaving the 
deubiquitinated RIP-1 (Lin et al. 1999; Rajput et al. 2011). Therefore, the association of 
caspase 8 and RIP-1 may lead to the reduction of functional RIP-1. Both c-FLIPL and 
p43FLIP recruit RIP-1 to caspase 8 in T lymphocytes, and p43FLIP binds to RIP-1 with 
higher affinity than do full-length c-FLIPL or pro-caspase 8 (Dohrman et al. 2005a). These 
data suggest that the long isoform of c-FLIP may contribute to the suppression of 
necroptosis via recruiting RIP-1 to caspase 8. Another possibility is that the pro-caspase 
8-c-FLIPL heterodimer functions as the negative regulator of necroptosis by restraining 
RIP-1 activity.  
The earliest direct evidence in the connection of c-FLIP and necroptosis was 
shown in cells dying through mixed types of cell death. Knockdown of c-FLIP by short 
hairpin RNA sensitized the resistant cell lines to FasL/IAP antagonist-induced cell death, 
which involves both apoptosis and necroptosis (Geserick et al. 2009). However, in this 
experimental setting c-FLIPL only marginally improved cell survival in the presence of z-
VAD-fmk, suggesting the major protective effect of c-FLIP is the result of caspase 
inhibition. Interestingly, c-FLIPL was shown to interfere with RIP-1 recruitment to the 
death-inducing DISC and cytosolic complex II in FasL/IAP antagonist treated cells, 
which is contradict to the previous published results that c-FLIPL recruits RIP-1 to 
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caspase 8 (Dohrman et al. 2005a). More direct data regarding the role of c-FLIPL in 
necroptosis were obtained from the study of TNF--induced RIP-3-dependent 
necroptosis in MEFs and CrmA-expressing 3T3 cells. c-FLIPL expression is indeed 
required for the protection against necroptosis in this experimental setting (Oberst et al. 
2011).  
c-FLIP proteins exhibit both anti-apoptosis and anti-necroptosis function in the 
cells that lack c-IAPs activity. c-IAP antagonist (Smac mimetics) treatment following 
TLR3 stimulation leads to the formation of “Ripoptosome”, a ~2MD intracellular death-
inducing complex (Feoktistova et al. 2011). Genotoxic etoposide depletes XIAP and c-
IAPs in cancer cells and also triggers the formation “Ripoptosome” (Tenev et al. 2011). 
The assembly of Ripoptosome requires the kinase activity of RIP-1. Assembled 
“Ripoptosome” contains RIP-1, FADD, caspase 8, and different isoforms of c-FLIP. 
Caspase 10 is detected in the TLR3-induced Ripoptosome, but not in the genotoxin-
induced Ripoptosome. Interestingly, the cellular ratio of different isoforms of c-FLIP 
may determine the fate of the cells. c-FLIPL is a negative regulator of Ripoptosome 
formation, though it is a component of the Ripoptosome. c-FLIPS, conversely, promotes 
the assembly of Ripoptosome. Ectopic expression of c-FLIPS results in increased necrotic 
cell death in HaCaT cells upon TLR3 activation (Feoktistova et al. 2011). These two 
studies did not show clear evidence regarding whether c-FLIPL-caspase 8 in the 
Ripoptosome fails to suppress RIP-1 kinase activity and necroptosis, in other words, 
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whether those cells truly die from necroptosis in the absence of z-VAD-fmk (Feoktistova 
et al. 2011; Tenev et al. 2011). At least, it is evident that c-FLIPL and c-FLIPS have 
different potentials in regulating apoptosis and necroptosis, and c-FLIPS may be a 
necroptosis promoter under certain conditions. 
1.5.4 c-FLIP in T lymphocyte  
c-FLIP protein is widely expressed in organs with the exception of colon, 
placenta and testis. The expression level is particularly high in the heart, skeletal muscle 
and lymphoid tissues (Irmler et al. 1997; Rasper et al. 1998). c-FLIPL protein is detectable 
in naïve T lymphocytes and slightly increased upon TCR activation (Chau et al. 2005). 
Activated T lymphocytes then downregulates the expression of c-FLIPL, which is 
correlated with their susceptibility of FasL-induced apoptosis (Irmler et al. 1997). 
Though the expression levels of c-FLIPS and c-FLIPR are much lower than that of c-FLIPL 
in the resting T cells, c-FLIPS and c-FLIPR are quickly upregulated upon TCR stimulation 
(Chau et al. 2005; Golks et al. 2005). The kinetic of c-FLIP protein level in cells suggests 
that they may protect activated T cells at the early stage of activation. 
c-FLIP proteins have been shown to be essential for T cell development. As c-
FLIP-deficiency causes embryonic lethality on day 10.5, the role of c-FLIP was studied in 
mouse model with specific deletion of c-FLIP in T-cell compartment or lethally 
irradiated recombination-activating gene 1 (Rag 1)-deficient mice reconstructed with c-
FLIP-deficient embryonic stem cells (rcFLIP) (Chau et al. 2005; Zhang and He 2005b; 
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Zhang et al. 2008a). In the rcFLIP mice, the thymocyte development is arrested at the 
CD25CD44 (DN2) and CD25CD44 (DN3) stage, resulting in a much smaller DP 
population compared to that in wild type mice. However, some thymocytes develop 
past those stages into DP and SP cells. The cellularity of rcFLIP thymocytes is greatly 
reduced, which is cause by both impaired thymocyte development and a deficiency of B 
cells (Chau et al. 2005). Study in the T cell specific c-FLIP-deficient mice can avoid the 
interference of defective B cells. c-Flipf/f Lck-Cre mice show normal thymocyte 
development from the DN to DP stage, probably because c-FLIP deletion starts at the 
DN2 stage in this model and already expressed c-FLIP protein protects the thymocytes 
to pass to DP stage. The SP thymocytes population is impaired in c-Flip f/f Lck-Cre mice 
and c-Flip SP cells fails to down-regulate their coreceptors (Zhang and He 2005b). In 
both model, the thymocytes defect is likely caused by enhanced apoptosis in vivo, as 
fresh isolated c-Flip thymocytes showed increase apoptosis in the presence or absence 
of TCR/Fas stimulation (Zhang and He 2005b). 
Survival of the mature T lymphocytes requires c-FLIP. c-FLIP protects mature T 
cell from TCR, Fas and TNF--induced cell death. Loss of c-Flip gene leads to severe 
TCR activation-induced apoptosis, while expression of either isoform of c-FLIP (c-FLIPL 
or c-FLIPR) is sufficient to rescue the death phenotype (Zhang et al. 2008a). Importantly, 
deletion of Tnf gene failed to improve cell survival upon TCR stimulation and Fas 
mutation (lpr/lpr) only showed partial rescue in the enhanced TCR-induced apoptosis in 
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c-FLIP-deficient T lymphocytes (Zhang et al. 2008a). These results suggest that c-FLIP 
may play a role beyond extrinsic death pathway. 
c-FLIPL is suggested to be involved in NF-B activation and signal regulated 
kinase (ERK) signaling in T lymphocytes. c-FLIPL interacts with TRAF1/2, RIP-1 and Raf-
1 in DISC (Kataoka et al. 2000). p43FLIP recruits TRAF2 and RIP-1 with higher affinity 
than full length of c-FLIP or caspase 8 (Kataoka and Tschopp 2004; Dohrman et al. 
2005a). Ectopic expression of c-FLIPL increases TCR activation-induced proliferation in T 
lymphocytes (Lens et al. 2002). However, all those studies addressing the role of c-FLIPL 
in T cell signaling were conducted in overexpression models. Studies in T-cell specific c-
FLIP deletion model later revealed that both NF-B and ERK activation are intact in c-
FLIP-deficient thymocytes and mature T cells. (Chau et al. 2005; Zhang and He 2005b). 
Moreover, JNK, p38 and IB-a phosphorylation are slightly increased in c-FLIPL-
deficient T cells upon TCR activation (Zhang et al. 2008b). It is consistent with the 
findings from the study of primary human keratinocytes, that knockdown of c-FLIP 
enhances FasL- and TRAIL-induced NF-B, JNK and p38 activation (Kavuri et al. 2011). 
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2. Materials and methodology 
2.1 Animals 
2.1.1 The generation of T-cell specific c-FLIP-deficient mice  
c-Flipf/f, c-FLIPL bacterial artificial chromosome (BAC) transgene and c-FLIPR BAC 
transgene mice were generated by a previous member in the laboratory (Zhang and He 
2005b; Zhang et al. 2008b; Zhang et al. 2008a). In brief, the exon 1 of c-Flip gene was 
flanked by two loxP sites in c-Flipf/f mice (Figure 5A). c-FLIPR BAC transgene and c-FLIPL 
BAC transgene were generated by fusing mouse c-FLIPR cDNA and c-FLIPR cDNA, 
including their own stop codon and poly(A) tails, to the start codon in exon 1 of c-Flip 
gene respectively (Figure 5B). A 60kb BAC fragment that is 15kb downstream of the 
nearest 5’ gene (Als2cr12) and 10kb upstream of the nearest 3’ gene (caspase-8) was used 
for injection to create BAC transgenic mice. T cell specific c-FLIPL-deficient mice were 
generated by crossing c-FLIPR BAC transgenic mice to c-FLIPf/f Lck-Cre mice. c-Flipf/f 
littermates were used as wild type controls. The major advantage for using the BAC Tg 
approach is to have the expression of transgene controlled by its endogenous regulatory 
elements. c-FLIP conditional knockout mice were generated by crossing c-Flipf/f to ER-
Cre mice. Animals were used at 6-8 weeks of age. Animal usage was conducted 
according to protocols approved by the Duke University Institutional Animal Care and 
Use Committee (IACUC).  
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Figure 6: Generation of c-FLIPL- and c-FLIPR-deficient T cells 
Figure 6. (A) Diagram of the c-FLIP targeting construct. E1-E4, exon 1 – exon 4 of 
the c-FLIP gene; EI, EcoRI; SI, SacI; L, loxP site; F, FRT site; DT, diphtheria toxin; Neo, 
neomycin-resistant gene. (B) Schematic of c-FIPR BAC transgene constructs. (C) Western 
blot analysis of c-FLIP expression in thymocytes of c-Flipf/f Lck-Cre, c-Flipf/f Lck-Cre c-
FLIPR-BAC Tg, c-Flipf/f Lck-Cre c-FLIPL-BAC Tg and wild type mice. Total thymocytes 
were blotted with anti-c-FLIP antibody (This figure is adapted from “An essential role 
for c-FLIP in the efficient development of mature T lymphocytes” © 2005 Rockefeller 
University Press. Originally published in Journal of Experimental Medicine. 202:395-
404. Figure 1A. And “The long isoform of cellular FLIP is essential for T lymphocyte 
proliferation through an NF-B-independent pathway”. © 2008. The American 
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Association of Immunologists, Inc. Originally published in Journal of Immunology., 
2008 Apr 15;180(8):5506-11. Figure 1). 
2.1.2 Genotyping  
Animals were genotyped by PCR. The reaction to determine the floxed and wild-
type c-FLIP alleles was performed at 94°C for 30 s, 61°C for 30 s, and 72°C for 60 s for 35 
cycles. The primers for the wild-type and floxed c-FLIP alleles were the same: forward, 
5'-CAT GAG CAC TGA GGG ACA CAG CAC-3′; reverse, 5'-CGG AGT TTG CTA CAG 
GAA GGC CAC-3'. The product of the wild type allele was 340 bp, while the product of 
the floxed allele was 480 bp. The reaction to determine the c-FLIPL transgene and c-
FLIPR transgene was performed at 94°C for 30 s, 52°C for 30 s, and 72°C for 120 s for 35 
cycles. The primers for the c-FLIPL transgene and c-FLIPR were the same: forward, 5'-
GAG GTT GAG GGA CTT GGC ATG-3′; reverse, 5'-TCA GCA GGA CCC TAT AAT 
CAG-3'. The reaction to determine the floxed and wild-type Atg3 alleles was performed 
at 94°C for 30 s, 60°C for 60 s, and 72°C for 60 s for 35 cycles. The primers for the wild-
type and floxed Atg3 alleles were the same: forward, 5'- CGA TGG CAT CTT ATG CTG 
AGC AAT G-3′; reverse, 5'- AAC CAT AGC CGT GGT GTC TGG TAA-3'. The product 
of the wild type allele was 748 bp, while the product of the floxed allele was 866 bp. The 
reaction to determine the Lck-Cre alleles was performed at 94°C for 30 s, 57°C for 30 s, 
and 72°C for 45 s for 35 cycles. The primers were: forward, 5'- gca gga agt ggg taa cta gac 
taa c-3′; reverse, 5'- tct ccc acc gtc agt acg tga gat at-3'. The reaction to determine the ER-
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Cre allele was performed at 94°C for 30 s, 61°C for 30 s, and 72°C for 45 s for 35 cycles. 
The primers were: forward, 5'- CCA CCA GCC AGC TAT CAA CT-3′; reverse, 5'- TGA 
ACC AGC TCC CTA TCT GC-3'. The reaction to determine the Bak knockout and wild-
type alleles was performed at 94°C for 30 s, 55°C for 30 s, and 72°C for 120 s for 35 
cycles. The forward primers for the wild-type and Bak knockout alleles were the same: 
5'-GAG CCA TGA AGA TGT TTA GC-3′. The reverse primer for the wild type allele 
was: 5'-GGT GTC CAC ACT AGA GAA CTA CTC-3'; for the Bak knockout allele was: 5'-
TCA GGA CAT AGC GTT GGC TAC-3'. The reaction to determine the Bax knockout 
and wild-type alleles was performed at 94°C for 30 s, 56°C for 60 s, and 72°C for 60 s for 
35 cycles. The forward primer for the wild-type allele was: 5'-CCG CTT CCA TTG CTC 
AGC GG-3′; for the Bax knockout alleles was: 5'-GTT GAC CAG AGT GGC GTA GG-3′. 
The reverse primers for the wild-type and Bak knockout alleles were the same: 5'-GAG 
CTG ATC AGA ACC ATC ATG-3'. The reaction to determine the Bim knockout and 
wild-type alleles was performed at 94°C for 30 s, 58°C for 60 s, and 72°C for 60 s for 35 
cycles. The forward primer for the wild-type allele was: 5'-GTG CTA ACT GAA ACC 
AGA TTA-3′; for the Bim knockout alleles was: 5'-CTC AGT CCA TTC ATC AAC AG-3′. 
The reverse primers for the wild-type and Bak knockout alleles were the same: 5'-CAT 
TCT CGT AAG TCC GAG TCT-3'. The reaction to determine the lpr and wild-type Fas 
alleles was performed at 94°C for 30 s, 59°C for 30 s, and 72°C for 60 s for 35 cycles. The 
forward primers for the wild-type Fas and lpr allele were the same: 5'-GTA AAT AAT 
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TGT GCT TCG TCA G-3’. The reverse primer for the wild-type allele was: 5'-CAA ATC 
TAG GCA TTA ACA GTG-3', for the lpr alleles were the same: 5'-TAG AAA GGT GCA 
CGG GTG TG-3'. 
2.2 Cell isolation and culture  
2.2.1 Lymphocyte isolation 
Single-cell suspensions were prepared from spleens or peripheral lymph nodes 
and re-suspended in ACK lysis buffer (0.15M NH4CL, 10mM KHCO3, 0.1mM EDTA 
pH7.4) for up to 3 minutes for red blood cell lysis. T lymphocytes were enriched using 
an EasySepTM mouse T cell negative enrichment kit from StemcellTM Technologies 
according to the manufacturer’s instructions. 
2.2.2 Cell culture  
Total splenocytes or enriched T lymphocytes were cultured in complete RPMI 
1640 medium containing 10% Fetal Bovine Serum (FBS) at 37C in the presence of 5% 
CO2 for indicated time. For naïve T cell culture, IL-7 (1 ng/ml; PeproTech) was added in 
the medium and re-added every 3 days. L929 cells were cultured in DMEM containing 
2mM Glutamine and 10% FBS at 37C in the presence of 5% CO2. Semi-confluent 
cultures of L929 cells were spitted using 0.25% trypsin/EDTA. 10 µM z-VAD-fmk 
(Sigma), 10 µM z-IETD-fmk (BD Pharmingen), 10 µM z-LEHD-fmk (BD Pharmingen), 2 
µg/ml anti-FasL (2MFL3, BioLegend), 100 nM necrostatin-1 (Enzo life science) and 
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10mM acetylcysteine (NAC) were add in lymphocyte cultures as indicated. For 
apoptosis induction, 10 M etoposide or 500 nM staurosporine was added in the culture. 
2.2.3 T cell activation 
T lymphocytes within total splenocytes were stimulated with soluble anti-CD3 
(2C11, 5 µg/ml, otherwise indicated in the figures). Anti-CD28 (clone 37.51, BioLegend, 2 
µg/ml) was added to several cultures as indicated. Enriched T lymphocytes were 
activated with plate-bound anti-CD3 and anti-CD28 (pre-incubation the culture dish 
with 5 µg/ml anti-CD3 and 2 µg/ml anti-CD8 in PBS at 4C overnight or at 37C for 1 
hour).  
2.2.4 In vitro inducible deletion  
Total splenocytes were cultured with 200 nM 4-hydroxy-tamoxifen (4-OHT; 
Sigma-Aldrich) for 3 day in the presence of IL-7 (1 ng/ml; PeproTech). Live cells were 
purified after deletion using Ficoll.  
2.3 Flow cytometry analysis 
Single-cell suspensions were prepared from spleens and lymph nodes after red 
blood cells lysis, or from T lymphocytes that were cultured for the indicated time. The 
cells were incubated with an FcR-blocking antibody (2.4G2), stained with FITC-, PE-, 
PE/Cy5-, APC-, APC-Cy7-, Pacific Blue or biotin-labeled mAbs on ice for 20 min, and 
washed with FACS buffer (2% FBS, 0.02% NaN3 in PBS). Cells stained with biotin-
labeled primary mAbs then stained with streptavidin-PE on ice for 20 min and washed. 
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A total of 0.5-20105 events were collected on a FACSCanto II flow cytometer (BD 
Biosciences) and analyzed using FlowJo software (Tree Star). All fluorescence-labeled 
Abs, including anti-CD3, anti-CD4, anti-CD8, anti-TCR, anti-CD19, anti-FasL, and anti-
Fas, were obtained from BioLegend. To stain cell surface FasL, cells were cultured with 1 
 protease inhibitor (Aprotinin, Sigma) for 4 hours immediately before staining.  
2.4 T cell proliferation assay 
After red blood cell lysis, splenocytes were incubated with 5 µM cell permeable 
carboxyfluorescein diacetate succinimidyl ester (CFDA-SE, Molecular Probes) in 5% 
FBS-PBS for 5 min at room temperature. Non-fluorescent CFDA-SE is processed by 
intracellular esterase, converting to fluorescent carboxyfluorescein succinimidyl ester 
(CFSE), which covalently binds to intracellular molecules. Cells were then washed with 
5% FBS-PBS for 3 times to remove surface binding. CFSE-labeled splenocytes were 
stimulated with anti-CD3 (2C11, 5 µg/ml) in the presence or absence of anti-CD28 (clone 
37.51; BioLegend, 2 µg/ml) for 2-3 days. Proliferation was determined by measuring 
CFSE dilution in live (7-AAD) CD4 or CD8 T cells by flow cytometry. 
2.5 Apoptosis/necrosis assays 
2.5.1 Annexin V staining.  
Cells were first stained for surface markers following the methods described 
above. Then cells were re-suspended in Annexin V-binding buffer (10 mM HEPES, pH 
7.4, 140 mM NaCl, 2.5 mM CaCl2) and incubated with Annexin V-PE (BD Bioscience) 
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and 7-AAD (BD Bioscience) at room temperature in for 15 min. The cells were then 
diluted in Annexin V-binding buffer and analyzed by flow cytometry within one hour. 
2.5.2 MOMP staining 
Cells were incubated with TMRE (40 nM) in complete RPMI at 37C for 20 min. 
After that, cells were stained with surface marker and 7-AAD (Invitrogen) in FACS 
buffer on ice for 15 min, and then washed with FACS buffer, stored on ice, and analyzed 
immediately. 
2.5.3 Fragmented DNA release assay. 
Four-week-old mice were injected i.p. with 1-1.5 mg 5-bromo-2'-deoxyuridine 
(BrdU) per animal per day for two weeks. Over 90% of the peripheral T lymphocytes 
were labeled with BrdU by the end of the injection period. The kinetics of fragmented 
DNA release were analyzed using a Cellular DNA Fragmentation ELISA kit (Roche 
Applied Science) following the manufacturer’s instruction. In brief, enriched naïve T 
lymphocytes were stimulated with plate-bound anti-CD3/anti-CD28 for the indicated 
time. Half of the supernatant was removed and stored at 4C. T cells (both live and 
dead) are spin-down and lysed. Half of volume of the T cell lysates and the saved 
supernatants (for 1:1 supernatant/cells ratio) at different time points were subjected to 
ELISA for BrdU, which represented the relative quantity of fragmented DNA. 
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2.5.4 Cytochrome c release 
T lymphocytes were enriched as 2.2.1 described. Cell purity was determined by 
flow cytometry to be >95%. Cytosol was released by digitonin in 80mM KCl buffer. The 
mitochondria/nuclei sample was prepared in the total cell lysis buffer (50 mM Tris-HCl 
pH 7.4], 150 mM NaCl, 2 mM EGTA, 2 mM EDTA, 0.2% Triton X-100, 0.3% NP-40 and 1 
× Protease Inhibitors). Cytochrome c release was tested by western blot. 
2.6 Western blot 
T cells were purified using an EasySepTM mouse T cell enrichment kit (Stemcell 
Technologies) according to the manufacturer’s instructions. For activated T cells, 
enriched T cells were cultured for 16-18 hours with plate bound anti-CD3. Cell purity 
was determined by flow cytometry to be >95%. Purified T cell lysates were prepared in 
sample buffer (50 mM Tris-HCl [pH 6.8], 50mM 2-ME, 2% SDS, 0.2% bromophenol blue, 
and 10% glycerol). The primary antibodies used for western blots were rat anti-c-FLIP 
(clone Dave-2; Alexis Biochemical), rabbit anti-full length caspase 8 (polyclonal, Cell 
Signaling), rabbit anti-active caspase 8 (polyclonal, Cell Signaling), mouse anti-RIP-1 
(38/RIP, BD Bioscience), rabbit anti-RIP-3 (polyclonal, Axxora), hamster anti-Bcl-2 
(polyclonal, BD pharmingen), rabbit anti-Bcl-xL (polyclonal), rabbit anti-Mcl-1 
(polyclonal, Rockland Immunochemicals), rabbit anti-Bim (polyclonal, Cell Signaling), 
rabbit anti-Bax (polyclonal, Cell Signaling), rabbit anti-Bak (polyclonal, Cell Signaling), 
rabbit anti-Bid (polyclonal, Abcam), mouse anti--Tubulin (B-5-1-2, Sigma) and goat 
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anti--Actin (polyclonal, Santa Cruz Biotechnology). For HRP-labeled western blot, the 
secondary antibodies were anti-rabbit IgG-HRP, anti-mouse IgG-HRP, anti-hamster IgG-
HRP and anti-goat IgG-HRP (Jackson Immunoresearch). The development of the 
western blot was achieved with SuperSignal West Pico Chemiluminescent substrate 
(Thermo Scientific). For fluorescent western blot, the secondary antibodies were anti-
rabbit IgG-Alexa Fluor 680, anti-mouse IgG-Alexa Fluor 680, and anti-goat IgG-Alexa 
Fluor 790 (Molecular Probes, Invitrogen). 
2.7 Autophagy detection  
2.7.1 LC3 fluorescence microscopy  
Enriched primary T lymphocytes were first stained with anti-LC3 (P015, MBL 
International), then stained with Cy3-, FITC- and Pacific Blue-labeled, anti-rabbit IgG, 
anti-CD4, and anti-CD8. All images were captured with a custom-built Zeiss Observer 
D1 using a Zeiss 3100 objective lens and a 1.4 numerical aperture. Images were captured 
using a Photometrics Cool SNAP HQ2 and analyzed using Metamorph software. Images 
were deconvoluted and thresholded. Deconvolution was done blind at 40 iterations. LC3 
positive staining is defined as >180% of background signal. LC3 puncta is defined as any 
enclosed LC3 positive staining area no smaller than 10 pixels. 
2.7.2 LC3 detection by western blot  
LC3-I/LC3-II ratio was analyzed by the western blot as described in 2.6. Anti-LC3 
(polyclonoal P015, MBL International) was used to detect LC3 protein. 
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2.7.3 Transmission electron microscopy  
Live naïve T lymphocytes were sorted into CD4 CD44low 7-AAD or CD8 
CD44low 7-AAD populations. For sorting of activated T cells, total splenocytes were 
cultured with anti-CD3 (2C11, 5 µg/ml) for 18 hours before activated cells were sorted 
into CD4 7-AAD or CD8 7-AAD populations. Cells were fixed in 4% gluteraldehyde 
in 0.1 M sodium cacodylate overnight and then pelleted and embedded in 2.5% molten 
agar and transferred into fresh fixative. The embedded cells were incubated in fresh 
fixative for a period of one hour to overnight. The specimens were rinsed twice with 0.1 
M sodium cacodylate buffer and post-fixed in 1% osmium tetroxide for 90 min. The 
specimens were then rinsed again in sodium cacodylate buffer and dehydrated through 
an ethanol series (50%, 70%, 95%, 95%, 100%, 100%) and placed in two changes of a 
transitional solvent (propylene oxide). The specimens were then placed in a 1:1 mixture 
of propylene oxide:epoxy resin 812 overnight before being placed in epoxy 812 for an 
hour and embedded. The blocks were polymerized in a 60C oven overnight. Ultrathin 
sections (90 nm) were cut with a Reichert-Jung Ultracut E ultramicrotome, placed on 
copper grids, and stained with uranyl acetate and Reynolds’ lead citrate. The specimens 
were viewed with a Phillips CM 12 transmission electron microscope equipped with an 
AMT XR-100 2Vu digital camera system. The intracellular double membrane structure 
was identified as autophagosomes. 
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2.8 RT-PCR.  
Total RNA was extracted from sorted freshly isolated T cells and T cells cultured 
for 16-18 hours with plate bound-anti-CD3. The primers for RIP-1 are: 1:5'-GGAAGGAT 
AATCGTGGAGGC-3' (forward, exon4) and 5'–AAGGAAGCCACACCAAGATC-3' 
(reversed, exon5). 
2.9 Reactive oxygen species (ROS) and mitochondria analysis 
Splenocytes were cultured in the presence or absence of anti-CD3 (5 µg/ml, 2C11) 
for 16 hours before staining. For ROS analysis, single cell suspensions were incubated 
with 2.5 mM CM-H2DCFDA (Invitrogen) in DPBS at 37°C for 15min or 2.5 mM 
dihydroethidium (DHE; Sigma-Aldrich) in RPMI 1640 medium at 37°C for 30 min. 
Mitochondria was stained by 100 nM MitoTracker®  Green (Invitrogen, Molecular 
Probes) in RPMI 1640 medium for 30 min. The cells were washed with RPMI 1640 
medium and then stained with anti-CD4-APC, anti-CD8-APC/Cy7, and 7-AAD, then 
washed with FACS buffer and analyzed by FACS immediately.  
2.10 Statistics 
Unpaired two-tailed Student’s t-tests were used to compare the means of 
different samples. 
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3. The role of c-FLIPL in the survival of activated T 
lymphocytes 
This chapter is adapted from “A role for c-FLIPL in the regulation of apoptosis, 
autophagy, and necroptosis in T lymphocytes”, Ming-Xiao He and You-Wen He, Cell Death and 
Differentiation. 2013 Feb;20(2):188-97. doi: 10.1038/cdd.2012.148.  
3.1 Introduction 
The size of the T lymphocyte compartment is tightly controlled by carefully 
balanced T cell expansion and apoptosis. Apoptosis plays critical in the regulation of T 
cell response, as death receptor Fas (CD95) ligation to FasL results in the deletion of re-
activated T cells through TCR activation-induced cell death (AICD) (Strasser et al. 2009). 
Recently, necroptosis was observed in activated T cells when the activity of caspase 8 is 
blocked (Bell et al. 2008; Osborn et al. 2010; Chen et al. 2011). Necroptosis was correlated 
with high level of autophagy in multiple types of cells including T lymphocytes, but 
whether excessive autophagy actually causes necroptosis remains controversial (Yu et 
al. 2004; Bell et al. 2008; Osborn et al. 2010; Ch'en et al. 2011b; Chen et al. 2011). Though 
several studies showed each of this process are involved in T cell response, the interplay 
of apoptosis, autophagy, and necroptosis in T lymphocytes remains poorly understood. 
c-FLIP is a potential regulator for all three of these pathways (apoptosis, autophagy, and 
necroptosis) in primary T lymphocytes.  
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c-FLIP proteins suppress extrinsic apoptosis pathway by inhibiting pro-caspase 8 
homodimerization and activation. (Budd et al. 2006). However, when dimerized with c-
FLIPL, pro-caspase 8 retains partial proteolytic activity (Kataoka and Tschopp 2004). In 
contrast, the formation of c-FLIPR-pro-caspase 8 heterodimers entirely inhibits pro-
caspase 8 activation (Budd et al. 2006). c-FLIPL and c-FLIPR are both expressed in mature 
T lymphocytes, and the expression of either isoform is sufficient to protect resting T cells 
from apoptosis (Zhang et al. 2008a). Why T cells require the expression of both isoforms 
remains to be studied. 
Previous reports suggested that c-FLIPL is involved in the regulation of 
necroptosis. c-FLIPL protects c-IAPs antagonist-treated cells from Fas-induced cell death, 
in which both apoptosis and necroptosis are involved (Geserick et al. 2009). 
Furthermore, c-FLIPL inhibits the formation of cell death inducing “Ripoptosome”, 
which functions in TLR3-induced apoptosis and necroptosis (Feoktistova et al. 2011). 
Silencing of c-FLIPL by siRNA sensitizes cells to TNF--induced RIP-1/RIP-3-dependent 
necroptosis (Oberst et al. 2011). However, the role of c-FLIPL in necroptosis has yet to be 
studied in primary T cells in a genetically deficient model. 
c-FLIP may also promote T cell survival though controlling threshold of 
autophagy. Overexpression of either isoform of c-FLIP protein suppresses autophagy, 
by the mechanism that c-FLIP competes with LC3 in Atg3 conjugation (Lee et al. 2009). 
On the other side, recent studies suggest a correlation between caspase 8 inhibition and 
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hyperactive autophagy (Yu et al. 2004; Bell et al. 2008; Wu et al. 2011). Whether c-FLIP 
regulates autophagy by itself or through controlling caspase 8 activity in primary cells 
has not yet been addressed. More importantly, whether enhanced autophagy leads to 
necroptosis in T lymphocytes remains controversial (Bell et al. 2008; Osborn et al. 2010; 
Ch'en et al. 2011). Thus, the role of c-FLIP in regulating autophagy and autophagy-
related cell death in primary T cells has yet to be determined. 
It was previously reported that c-FLIPL-deficient T cells failed to respond to 
Listeria monocytogenes infection (Zhang et al. 2008b). In this chapter, it will be shown that 
c-FLIPL-deficient T cells fail to proliferate upon TCR stimulation due to extensive Fas-
dependent cell death. Both apoptosis and RIP-1-dependent necroptosis contribute to the 
loss of cellularity after T cell activation. Interestingly, c-FLIPL-deficient T cells generate 
more active caspase 8 (p18) than wild type T cells, indicating that the apoptotic and anti-
necrotic activities of caspase 8 may be independent. In addition, the autophagy 
induction in c-FLIPL-deficient T cells is increased, which in fact promotes T cell survival. 
Together, our results identify c-FLIPL as a key regulator of apoptosis, necroptosis, and 
autophagy in primary T lymphocytes. 
3.2 Result 
3.2.1 c-FLIPL-deficient T lymphocytes display enhanced cell death 
upon TCR stimulation.  
c-FLIPR BAC transgenic mice were crossed to c-Flipf/f Lck-Cre mice to generate 
conditional knockout mice that only c-FLIPL is absent in T lymphocytes (referred to as c-
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FLIPLmice). The study in c-FLIPLmice showed that c-FLIPL was dispensable for T 
cell development and naïve T cell survival. However, c-FLIPLmice failed to generate 
effector T-cell responses against L. monocytogenes infection in vivo (Zhang et al. 2008b). 
The impaired effector response in c-FLIPL mice was initially attributed to defective T 
cell proliferation. In vitro T cell proliferation assay showed that the proliferation of c-
FLIPL-deficient T cells is defective (Figure 7). 
 
Figure 7: Defective proliferation upon TCR stimulation in c-FLIPL-deficient T 
lymphocytes 
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Figure 7. T cell proliferation 24 hours (A) or 72 hours (B) after the initial TCR 
activation. Total splenocytes from c-FLIPL and wild type (c-Flipf/f) mice were labeled 
with CFSE, stimulated with anti-CD3 in the absence or presence of anti-CD28. Cell 
proliferation was determined by flow cytometry after 24 hours (A) and 72 hours (B). 
Numbers represent the frequency of T cells that have undergone cell proliferation. 
Histograms were gated on the 7-AAD CD4 or 7-AAD CD8 populations. The grey area 
represents un-stimulated T cells. Data are representative of >3 experiments. 
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Because impaired proliferation could be caused by enhanced cell death, we then 
analyzed apoptosis and cell death by Annexin V /7-AAD staining. We found that the 
death rate of c-FLIPL-deficient T cells upon TCR stimulation was dramatically increased 
when compared to that in wild type T cells. Regardless of the strength of the TCR signal, 
a majority of c-FLIPL-deficient T cells (both CD4 and CD8) died within 36 hours upon 
simulation (Figure 8A). Fewer survived cells were detected at 40 hours after TCR 
stimulation (Figure 8B). We also examined cell death using mitochondrial outer 
membrane permeabilization (MOMP) staining and observed similar results (Figure 9) 
The decreased numbers of live c-FLIPL T were apparent less than 24 hours after TCR 
stimulation. This result suggested that this phenomenon was not attributable to 
impaired T cell proliferation, as T lymphocytes did not divide during the first 24 hours 
(Figure 7A). In contrast to these results, c-FLIPL-deficient T cells displayed no survival 
defect in the absence of TCR stimulation (Figure 8 and 9), likely due to the protective 
effect of c-FLIPR. Interestingly, we observed that c-FLIPL CD4 T cells consistently 
exhibited slightly better survival rate than wild type T cells in the absence of TCR 
stimulation (Figure 8 and 9). The cell survival defect after T cell activation was only 
observed in c-FLIPL-deficient T cells, but not in c-FLIPR-deficient T cells (Figure 10A), 
though both isoforms were expressed in mature T lymphocytes (Figure 10B). 
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Figure 8: Enhanced cell death upon TCR activation in c-FLIPL-deficient T 
lymphocytes 
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Figure 8. (A) Time course analysis of the survival rate of naïve and activated c-
FLIPL T cells. Total splenocytes were stimulated with different concentrations anti-CD3 
in the presence or absence of anti-CD28 as labeled. The cell survival rates of CD4 and 
CD8 T cells were analyzed by flow cytometry at different time points after TCR 
activation. Live cells were analyzed by gating on the Annexin V 7-AAD population 
within the total CD4 or CD8 populations (n=4). (B) Cell death rate of naïve or activated 
c-FLIPL T cells after 40 hours of culture. Total splenocytes were cultured in the 
presence or absence of anti-CD3 (5 mg/ml) for 40 hours. Cell death rates were analyzed 
as described in A (n=6). All error bars represent the standard error of the mean (s.e.m.). 
* P<0.05, ** P<0.01, *** P<0.001. 
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Figure 9: Enhanced MOMP after TCR stimulation in c-FLIPL-deficient T 
lymphocytes. 
Figure 9. TMRE staining of c-FLIPL T cells upon TCR stimulation. Total 
splenocytes were cultured in the absence or presence of anti-CD3 (5µg/ml) for 40 hours. 
At different time points after activation, the cells were incubated with TMRE for 30 min 
then stained with 7-AAD on ice for 15 min. Labeled cells were analyzed by flow 
cytometry. Live cells were analyzed by gating on the TMREhigh 7AAD population 
within the total CD4 or CD8 populations (n=3). All error bars represent the standard 
error of the mean (s.e.m.). * P<0.05, ** P<0.01. 
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Figure 10: Normal survival after TCR stimulation in c-FLIPR-deficient T 
lymphocytes 
Figure 10. (A) Cell death upon TCR stimulation in c-FLIPL-deficient T cells. Total 
splenocytes from c-Flipf/f and c-Flipf/f ER-Cre c-FLIPL-Tg mice were cultured for 3 days in 
the presence of 4-hydroxy-tamoxifen (0.2 M) and IL-7 (1 ng/ml) to generate wild type 
and c-FLIPR cells. Live cells were isolated using Ficoll, stimulated with plate-bound 
anti-CD3, and cultured for 40 hours with IL-7 (1 ng/ml). Cell death was analyzed by 
flow cytometric analysis of 7-AAD staining. (B) c-FLIPL and c-FLIPR expression levels in 
T lymphocytes. Total splenocytes from c-Flipf/f and c-Flipf/f ER-Cre mice were cultured as 
(A). Live T cells were enriched and then lysed with protein sample buffer. Numbers 
underneath each band show the relative expression level after normalized to -Actin. 
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c-FLIPL functions downstream of death receptor signals (Budd et al. 2006). As the 
death receptor Fas and its ligand FasL are both expressed in activated T cells, c-FLIPL 
likely protects T cells from Fas-induced cell death upon TCR stimulation. Therefore, we 
tested whether blocking Fas signaling improved c-FLIPL-deficient T lymphocyte 
survival. Indeed, anti-FasL mAb treatment completely rescued the survival defect in c-
FLIPL CD4 T cells and partially rescued the survival defect in c-FLIPL CD8 T cells 
(Figure 11A). In contrast, anti-FasL mAb treatment did not further enhance cell survival 
in wild type T lymphocytes, as these cells are fully protected by endogenous c-FLIP. We 
further confirmed the role of Fas in the death of activated c-FLIPL T cells by crossing c-
FLIPL mice to lpr/lpr mice, which do not express functional Fas on cell surfaces (Adachi 
et al. 1993). The survival of T cells from c-FLIPLlpr/lpr mice was comparable to that of 
T cells from wild type or lpr/lpr mice (Figure 11B). Importantly, rescuing the survival of 
c-FLIPL-deficient T cell restored their ability to proliferate (Figure 11C), suggesting that 
the impaired effector T cell expansion upon TCR stimulation observed in c-FLIPL mice 
is a secondary effect of enhanced cell death. Interestingly, when the Fas-FasL interaction 
was blocked, c-FLIPL-deficient T cells consistently proliferated slightly faster than wild 
type T cells, whereas anti-FasL mAb treatment showed no effect on wild type T cell 
proliferation at all. These data are consistent with the fact that NF-κB signaling is 
increased in c-FLIPL-deficient T lymphocytes (Zhang et al. 2008b). Taken together, these 
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findings indicate that the enhanced cell death in activated c-FLIPL T cells requires Fas-
FasL ligation.  
We then tested whether c-FLIPL-deficient cells expressed different levels of death 
receptors or death receptor ligands. Our results showed that both naïve and activated c-
FLIPL-deficient T lymphocytes expressed Fas at levels comparable to those in wild type 
T cells (Figure 12A). As FasL expression in naïve T cell is undetectable, we analyzed cell 
surface FasL 24 hours after TCR stimulation. Similar expressions of FasL were observed 
in wild type and c-FLIPL T lymphocytes (Figure 12B). These results show that the 
enhanced Fas-dependent cell death in c-FLIPL-deficient T cells was not due to changes in 
the expression of Fas or FasL. Therefore, intracellular Fas signaling causes the cell death 
when the protection of c-FLIPL is lost. 
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Figure 11: Fas-dependent increased cell death in activated c-FLIPL-deficient T 
lymphocytes 
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Figure 11. (A) The effect of blocking FasL on cell death in TCR-stimulated c-
FLIPL T cells. Total splenocytes were stimulated with anti-CD3 (5 g/ml) and cultured 
for 40 hours. Anti-FasL mAb was added in some cultures as indicated. The cell survival 
rates of T cells were analyzed by Annexin V/7-AAD staining. Live cells were gated on 
the Annexin V 7-AAD population within the total CD4 or CD8 populations (n=5). (B) 
Cell death of c-FLIPL T cells and c-FLIPLlpr/lpr T cells. (n=4). Cell death of CD4 (left) 
and CD8 (right) T cells was analyzed as described in (A). All error bars represent the 
standard error of the mean (s.e.m.). * P<0.05, ** P<0.01, *** P<0.001. (C) Effect of anti-
FasL mAb on the proliferation of c-FLIPL-deficient T cells. Total splenocytes from c-
FLIPL and wild type (c-Flipf/f) mice were labeled with CFSE, stimulated with anti-CD3, 
and cultured for 72 hours in the presence or absence of anti-FasL mAb. Histograms were 
gated on 7-AAD CD4 (left) and 7-AAD CD8 (right) populations. The data shown 
were representative of >3 independent experiments.  
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Figure 12: Comparable Fas and FasL expression between wild type and c-
FLIPL T cells 
Figure 12. (A) Fas expression on wild type and c-FLIPL T cells. Naïve and 
activated T lymphocytes (16 hours after anti-CD3 activation) were stained with anti-Fas-
PE. The dashed line represents the isotype control. (B) FasL expression on activated wild 
type and c-FLIPL T cells. Total splenocytes were activated with anti-CD3 for 20 hours. 
FasL was stained after 4 hours of treatment with protease inhibitor. The grey area 
represents the isotype control. Data are representative of >3 experiments. 
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3.2.2 c-FLIPL-deficient T cell death is partially mediated through 
caspase-dependent apoptosis. 
As c-FLIPL inhibits death receptor-mediated caspase 8 activation (Budd et al. 
2006), we next investigated whether the loss of c-FLIPL led to increased caspase activity 
and apoptosis in T lymphocytes. Active caspase 8 (p18) was not detected in naïve T cells 
regardless of c-FLIPL expression. However, after TCR stimulation, c-FLIPL-deficient T 
cells generated large amount of active caspase 8 (p18), and blocking Fas-FasL interaction 
with the anti-FasL blocking antibody completely prevented active caspase 8 generation 
(Figure 13A). The accumulation of pro-caspase 8 upon blockade of FasL in both wild 
type and c-FLIPL T cells suggested Fas-dependent cleavage of pro-caspase 8 in 
activated T cells. However, active caspase 8 (p18) was not significantly generated in wild 
type T cells, probably because c-FLIPL suppresses complete cleavage of caspases 8. Pro-
caspase 8 level was increased in activated T cells, likely because the catalytic activity of 
pro-caspase 8 is essential for T cell survival upon T cell activation (Leverrier et al. 2011). 
We further tested whether suppressing active caspase 8 generation and apoptosis could 
rescue the cell survival defect in c-FLIPL-deficient T cells. Surprisingly, the caspase 8 
inhibitor z-IETD-fmk only partially rescued the survival defect in c-FLIPL CD4 T cells 
and failed to rescue that of c-FLIPL CD8 T cells (Figure 13B). Similar results were 
obtained using the pan-caspase inhibitor z-VAD-fmk to block apoptosis (Figure 13B).  
We next analyzed the kinetics of apoptosis in c-FLIPL-deficient T cells. At early 
stages of apoptosis, phosphatidylserine on the cell surface can be stained by Annexin V. 
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We used Annexin V to detect cells undergoing apoptosis and 7-AAD to label cells that 
lost their plasma membrane integrity. Upon TCR stimulation, the frequencies of 
Annexin V cells among 7-AAD cells were initially higher in c-FLIPL T cells (Figure 
13C). During 12-16 hours after TCR stimulation, the rate of apoptotic cells became 
comparable in wild type and c-FLIPL T cells. At a later time point (32 or 40 hours), 
more apoptotic cells were detected in the c-FLIPL CD4 and CD8 T cells (Figure 13C 
and 13D). Meanwhile the death rate (7-AAD) steadily increased in c-FLIPL-deficient 
cells (Figure 14). Although apoptosis was enhanced in c-FLIPL-deficient T cells, 
inhibiting caspases fails to rescue the enhanced cell death, suggesting that a non-
apoptotic cell death might contribute to the enhanced death observed in c-FLIPL-
deficient T cells. 
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Figure 13: Enhanced apoptosis in c-FLIPL-deficient T lymphocytes upon TCR 
stimulation 
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Figure 13. (A) Western blot analysis of caspase 8 activation in c-FLIPL-deficient T 
cells. Total splenocytes from c-FLIPL and wild type mice were activated with anti-CD3 
for 18 hours. T lymphocytes were enriched (>95%) and lysed for blotting. The data 
shown are representative of 3 independent experiments. (B) The effect of caspase 
inhibitors on cell death in c-FLIPL-deficient T cells. Total splenocytes were stimulated 
with anti-CD3 (5 g/ml) and cultured for 40 hours in the presence of z-VAD-fmk or z-
IETD-fmk, and cell survival was measured by Annexin V and 7-AAD staining. Live cells 
were analyzed by gating on the Annexin V 7-AAD population within the total CD4 or 
CD8 populations (n=6). (C) The kinetics of apoptotic rates in c-FLIPL T cells. Total 
splenocytes were stimulated with anti-CD3 and analyzed by flow cytometry at different 
time points (n=2). Annexin V % was calculated as follows: the number of Annexin V 7-
AAD CD4 (or CD8) cells divided by the total number of 7AAD CD4 (or CD8) cells. 
(D) Apoptotic rates 16 hours (n=6) and 40 hours (n=4) after TCR stimulation. All error 
bars represent the standard error of the mean (s.e.m.). * P<0.05, ** P<0.01, *** P<0.001. 
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Figure 14: Kinetics of cell death after TCR stimulation in c-FLIPL-deficient T 
lymphocytes 
Figure 14. Time course of the survival rate of activated c-FLIPL T cells. Total 
splenocytes were stimulated with anti-CD3. The cell survival rates of CD4 and CD8 T 
cells were analyzed by flow cytometry at different time points after TCR activation. Data 
are representatives of 2 independent experiments. 
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3.2.3 c-FLIPL-deficient T cells undergo necroptosis upon TCR 
stimulation. 
Because our results suggested that c-FLIPL-deficient T lymphocytes might die 
through a non-apoptotic pathway upon TCR stimulation, we then analyzed whether 
activated c-FLIPL T cells died through necrosis. Apoptosis is characterized by the 
generation of mononucleosomal and oligonucleosomal DNA fragments, which are 
released first to the cytosol during early stages of apoptosis and then outside the cells at 
the late stage of apoptosis (Wyllie 1980). In contrast, necrotic cells directly release 
randomly digested DNA into the culture medium as they lose membrane integrity. We 
confirmed these two fragmented DNA releasing patterns in typical necroptotic (z-VAD-
fmk treated) and apoptotic (etoposide treated) L929 cells by ELISA (Bonelli et al. 1996; 
Yu et al. 2004). z-VAD-fmk treated L929 cells immediately released fragmented DNA to 
the supernatant; whereas etoposide treated L929 cells showed a pattern of DNA release 
typical of apoptosis: the fragmented DNA was first detected in cytosol before releasing 
to supernatant (Figure 15A). We thus assessed the release of fragmented DNA in wild 
type and c-FLIPL T cells upon TCR stimulation. The fragmented DNA release in wild 
type T cells was similar to the pattern of apoptosis. In contrast, c-FLIPL-deficient T cells 
quickly released fragmented DNA to the supernatant, which was a sign of ongoing 
necrosis. Remarkably, certain level of fragmented DNA was detected in the cytosol of 
activated c-FLIPL T cells, probably because some of cells died from apoptosis in the 
meantime (Figure 15B). We also test whether cell death observed in c-FLIPL-deficient T 
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cells is caspase 3-dependent. In this assay, colorless NucViewTM 488 caspase 3 substrate 
and EthD-1 were added in cell culture and those cells were imaged by live microscopy 
after TCR stimulation. Cell membrane-permeable NucViewTM 488 caspase 3 substrate is 
cleaved by intracellular active caspase 3 to release a high-affinity fluorescent DNA dye 
(488nm). EthD-1 is impermeable for live cells with intact cell membrane. When cell 
membrane is ruptured, EthD-1 enters the cells, binds to nuclear DNA and emits red 
fluorescence (617nm). Therefore, the kinetic of green and red fluorescence represents 
whether the occurring cell death is caspase 3-dependent (Figure 15C). Not surprisingly, 
wild type T cells showed plasma membrane rupture over 15 minutes after caspase 3 
activation. However, more than a quarter of c-FLIPL-deficient T cells lost their cell 
membrane integrity before caspase 3 activation. Another 28% c-FLIPL-deficient T cells 
showed shortened time frame between caspase 3 activation and plasma membrane 
rupture (Figure 15D). Taken together, these results suggest that at least a portion of c-
FLIPL-deficient T cells die through caspase 3-independent necrosis.  
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Figure 15: Necrosis in c-FLIPL-deficient T lymphocytes after TCR stimulation 
  
  104 
Figure 15. (A) Release of fragmented DNA in L929 cells. L929 cells were labeled 
with BrdU in vitro. Apoptosis and necroptosis were induced by etoposide and z-VAD-
fmk, respectively. (B) Release of fragmented DNA in T lymphocytes upon TCR 
activation. T cells in c-FLIPL and control mice were labeled in vivo by i.p. BrdU 
injection and stimulated in vitro with plate-bound anti-CD3 for the indicated periods of 
time. BrdU-labeled fragmented DNA was measured in cell lysates and supernatants by 
ELISA. (C) Illustration of caspase 3 activation and plasma membrane rupture kinetic 
assays. Bottom is the model of a cell die in a caspase 3-dependent pathway. (D) Caspase 
3-independent death in c-FLIPL-deficient T cells. Naïve T cells were stimulated by anti-
CD3 and imaged by live fluorescent microcopy for 8 hours. The time point of caspase 3 
activation (Green) and cell death (EthD-1) were recorded for each cell that is EthD-
1by the end of the 8 hours. The time frame between caspase 3 activation and cell death 
was calculated as tn= Tcell deah-Tcaspase 3+. More than 50 cells were examined in each group.  
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Previous data suggested that c-FLIPL might recruit RIP-1 to the DISC and lead to 
caspase 8-dependent RIP-1 cleavage (Dohrman et al. 2005a; Rajput et al. 2011). 
Therefore, we investigated whether RIP-1 is involved in the death of c-FLIPL-deficient T 
lymphocytes. The mRNA level of RIP-1 was not increased in c-FLIPL T cells before and 
after TCR stimulation (Figure 16A). However, the protein level of RIP-1 was higher in 
naïve c-FLIPL T cells than controls. Sixteen hours after TCR stimulation, the difference 
was more obvious (Figure 16B). The level of RIP-1 became comparable between c-
FLIPL and wild type T cells 24 hours after TCR stimulation, probably due to the 
excessive death of cells with high level of RIP-1. The expression of RIP-3, another protein 
essential for necroptosis induction, was slightly increased without c-FLIPL in T 
lymphocytes (Figure 16B). Moreover, the RIP-1 inhibitor necrostatin-1 (referred as Nec-
1) partially rescued the enhanced cell death (Figure 16C) and completely restored the 
defective proliferation capacity in c-FLIPL-deficient T cells (Figure 16D). More 
importantly, combined treatment with the caspase 8 inhibitor z-IETD-fmk and 
necrostatin-1 completely rescued the enhanced cell death observed in c-FLIPL CD4 T 
cells (Figure 16C). Taken together, these results indicate that besides apoptosis, c-FLIPL-
deficient T cells also undergo RIP-1-dependent necroptosis upon TCR activation. 
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Figure 16: RIP-1-dependent necroptosis in c-FLIPL-deficient T lymphocytes 
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Figure 16. (A) RIP-1 mRNA levels in resting or activated c-FLIPL T cells. For 
naïve T cells, live CD44low CD4 or CD8 T cells were sorted from freshly harvested 
splenocytes. For activated T cells, total splenocytes were activated with anti-CD3 for 18 
hours, and live CD4 or CD8 T cells were sorted. (B) RIP-1 and RIP-3 protein expression 
in resting or activated c-FLIPL T cells. Live T lymphocytes were enriched (>95%) for 
blotting. The numbers underneath each band represent the relative expression level after 
normalization to -Actin. (C) Effect of necrostatin-1 and z-IETD-fmk on the cell death of 
c-FLIPL T cells. Total splenocytes were stimulated with anti-CD3 (5 g/ml) and 
cultured in the presence or absence of necrostatin-1 (Nec-1, 100nM) and z-IETD-fmk (10 
M) for 40 hours. Cell survival was tested by flow cytometry. Live cells were analyzed 
by gating on the Annexin V 7-AAD population within the total CD4 or CD8 
populations. All error bars represent the standard error of the mean (s.e.m.). * P<0.05, *** 
P<0.001. (D) Effect of necrostatin-1 on the proliferation of c-FLIPL T cells. Total 
splenocytes from c-FLIPL and wild type (c-Flipf/f) mice were labeled with CFSE, 
stimulated with anti-CD3, and cultured for 24 hours. Nec-1 was added at the beginning 
of the culture period. Histograms were gated on 7-AAD CD4 populations. The data 
shown were obtained in 3 independent experiments.  
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3.2.4 Autophagy is enhanced in c-FLIPL-deficient T lymphocytes 
A correlation of necroptosis and excessive autophagy was observed in several 
researches (Yu et al. 2004; Bell et al. 2008; Chen et al. 2011). Hence, we investigated 
whether the c-FLIPL deficient T lymphocytes displayed altered levels of autophagy. LC3-
I/LC-3 II conversion in mammalian cells is a reliable marker for autophagy induction 
(Klionsky et al. 2008). After TCR stimulation (18 hours), LC3-II:LC3 ratio increased in 
both wild type and c-FLIPL T cells; however, LC3-II levels were much higher in 
activated c-FLIPL T cells than in wild type T cells (Figure 17A). We next counted the 
number of LC3 puncta per cell as a measure of the number of autophagosomes 
(Klionsky et al. 2008; McLeod et al. 2011). Naïve and activated c-FLIPL T cells 
displayed significantly more LC3 puncta than did wild type T cells. Additionally, the 
increase in LC3 puncta in c-FLIPL-deficient T cells was more dramatic after TCR 
stimulation (Figure 17B). We further analyzed the intracellular structures in wild type 
and c-FLIPL T cells by transmission electron microscopy (TEM). Activated c-FLIPL T 
cells contained more intracellular double-membrane vacuoles (autophagosomes) than 
wild type T cells (Figure 17C, D), and the percentage of cells containing autophagosomes 
was much higher in activated c-FLIPL T cells than in wild type T cells (Figure 17E). 
Additionally, autophagy levels were also higher in naïve c-FLIPL T cells than in wild 
type T cells (Figure 17F, G). Interestingly, we observed an accumulation of membrane-
containing autophagosomes in naïve c-FLIPL T lymphocytes, which were entirely 
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absent in naïve wild type T cells (Figure 17F, H). The significance of these structures 
remains unclear. Together, these data demonstrate that c-FLIPL-deficient T cells display 
enhanced autophagy induction, especially after T cell activation. 
 
Figure 17: Enhanced autophagy in c-FLIPL-deficient T lymphocytes 
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Figure 17. (A) Western blot analysis of LC3 in resting and activated c-FLIPL T 
cells. T cells were activated with anti-CD3 for 18 hours, and LC3-I/LC3-II conversion was 
measured by western blot. (B) The numbers of LC3 puncta in c-FLIPL T cells. Activated 
T cells were intracellularly stained with anti-LC3 and analyzed for LC3 puncta by 
fluorescent microscopy. (C) TEM images of c-FLIPL T cells. Total splenocytes were 
activated with anti-CD3 for 18 hours. Activated wild type CD4 (I) or CD8 (IV) and c-
FLIPL CD4 (II, III) or CD8 (V, VI) T cells were sorted and analyzed by TEM. III and VI 
are enlarged images of II and V, respectively. Bars represent 0.5 µm in I-V and 100 nm in 
VI. Shown are representative micrographs. (D) Numbers of autophagosomes per cell in 
activated T lymphocytes (n60). (E) Percentages of activated T cells containing 
autophagosomes among all activated T cells counted in D. (F) Accumulated membrane 
inside autophagosomes in naïve c-FLIPL T cells. Naive wild type CD4 (I) or CD8 (IV) 
and c-FLIPL CD4 (II, III) or CD8 (V, VI, VII) T cells were sorted (CD44low) and 
analyzed by TEM. III is an enlarged image of II. V and VII are enlarged images of IV. 
Bars represent 0.5 µm in I-II and IV-V, 100 nm in III, VI and VII. Shown are 
representative micrographs. (G) Percentages of naive T cells containing autophagosomes 
among all naïve T cells (n50). (H) Percentages of naïve T cells in which membrane-
autophagosomes were observed among all naïve cells. Auto stands for 
autophagosomes; M-Auto stands for membrane-containing autophagosomes. All error 
bars represent the standard error of the mean (s.e.m.). * P<0.05, *** P<0.001. 
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Over-expression of c-FLIP protein inhibits autophagy in several cell lines (Lee et 
al. 2009). However, whether c-FLIP expression in primary T cells has a similar effect 
remains unclear. We thus assessed autophagy level in activated T cells expressing c-FLIP 
isoform-specific BAC transgenes (referred to as c-FLIPR-Tg and c-FLIPL-Tg). Both c-
FLIPR-Tg and c-FLIPL-Tg inhibited LC3 puncta formation upon TCR stimulation; 
however, c-FLIPR-Tg inhibited autophagy more efficiently than c-FLIPL (Figure 18). The 
difference in the ability of c-FLIPR-Tg and c-FLIPL-Tg to inhibit autophagy in activated T 
cells is likely due to post-transcriptional regulation in c-FLIP proteins. c-FLIPR is 
preferentially expressed in T cells (Figure 10B), resulting in higher protein levels of c-
FLIPR-Tg than c-FLIPL-Tg. These data suggest that c-FLIP can modulate the level of 
autophagy in activated T lymphocytes. 
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Figure 18: c-FLIPL and c-FLIPR inhibit autophagy induction in T lymphocytes. 
Figure 18. Reduced autophagy induction in c-FLIPL- BAC transgene or c-FLIPR-
BAC transgene expressing T lymphocytes upon TCR stimulation. Enriched T cells were 
activated with plate-bound anti-CD3 for 18 hours and then intracellularly stained with 
anti-LC3. LC3 puncta were analyzed by florescent microscopy. All error bars represent 
the standard error of the mean (s.e.m.).  
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3.2.5 Enhanced autophagy plays a cytoprotective role in c-FLIPL-
deficient T lymphocytes. 
Conflicting findings have been reported regarding the role of caspase inhibition-
mediated autophagy in cell death. Previous studies have concluded that autophagy 
either causes (Yu et al. 2004; Yu et al. 2006; Chen et al. 2011) or protects cells from z-
VAD-fmk-induced necrotic cell death (Wu et al. 2008). Studies of T lymphocytes suggest 
that autophagy may be the cause of the RIP-1-dependent cell death observed in 
dominant negative FADD-expressing T lymphocytes, but not of that observed in Fadd 
or caspase-8 T lymphocytes (Bell et al. 2008; Osborn et al. 2010; Ch'en et al. 2011). We 
therefore tested the role of autophagy in the death of c-FLIPL-deficient T lymphocytes. 
Atg3 plays an essential role in autophagosome formation by catalyzing LC3 processing 
(Levine et al. 2011). Inducible short term deletion of Atg3 in T lymphocytes resulted in 
reduced autophagy induction (Figure 19A), but did not cause enhanced cell death (Jia 
and He 2011) (Figure 19B). Therefore, we crossed c-FLIPL-deficient (c-FLIPf/f c-FLIPR-BAC 
Tg) mice to Atg3f/f ER-Cre mice. In this model, c-FLIP and Atg3 are successfully deleted 
in vitro upon 4-hydroxy-tamoxifen treatment (Zhang et al. 2008a; Jia and He 2011). We 
found that the loss of Atg3 further decreased cell survival in c-FLIPL-deficient T cells, 
especially upon TCR stimulation (Figure 19C). These data suggest that autophagy plays 
a cytoprotective role in activated c-FLIPL T lymphocytes. 
  114 
 
Figure 19: The cytoprotective role of autophagy in c-FLIPL-deficient T 
lymphocytes 
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Figure 19. (A) Reduced autophagy induction in Atg3 T cells. Total splenocytes 
from Atg3f/f and Atg3f/f ER-Cre mice were cultured for 3 days in the presence of 4-
hydorxy-tamoxifen and IL-7 to induce deletion, resulting in wild type and Atg3 
lymphocytes. T cells were negatively enriched by selection kit and activated with plate 
bound anti-CD3 for 18 hours. LC3-I/LC3-II conversion was measured by western blot. 
(B) Cell death upon TCR stimulation in Atg3 T cells (n>=3). (C) The effect of autophagy 
inhibition in the survival of c-FLIPL-deficient T cells (n=5). Total splenocytes from Atg3f/f 
and Atg3f/f ER-Cre mice (B) or c-Flipf/f Atg3f/f, c-Flipf/f c-FLIPR-Tg ER-Cre, c-Flipf/f Atg3f/c-
FLIPR-Tg ER-Cre and c-FLIPf/f c-FLIPR-Tg Atg3f/f ER-Cre mice (C) were cultured for 3 
days in the presence of 4-hydorxy-tamoxifen and IL-7 to induce deletion, resulting in 
wild type and Atg3 (B) or wild-type, c-FLIPL, c-FLIPLAtg3 and c-FLIPLAtg3 
cells (C). Live cells were isolated using Ficoll, stimulated with plate-bound anti-CD3, 
and cultured for 40 hours with IL-7 (1 ng/ml). Live cells were analyzed by gating on the 
7-AAD population within the CD4 or CD8 populations (n>=4). 
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3.2.6 Necroptosis in c-FLIPL-deficient T cells involves reactive oxygen 
species (ROS). 
Reactive oxygen species contribute to the execution of necroptosis (Yu et al. 2006; 
Chen et al. 2011). Cell-permeate 2',7'-dichlorodihydrofluorescein diacetate (CM-
H2DCFDA) staining showed that the hydrogen peroxide is slightly increased in c-FLIPL-
deficient T cells under both resting and activated conditions (Figure 20A). However, the 
level of superoxide radicals (stained by dihydroethidium, DHE) in c-FLIPL-deficient T 
cells seems to be comparable that in wild type T cells, under both resting and activated 
conditions (Figure 20B). Antioxidant acetylcysteine (NAC) partially inhibited TCR-
induced cell death in both wild type and c-FLIPL T cells. Moreover, adding RIP-1 
inhibitor Nec-1 to NAC treated cells did not improve the cell survival (Figure 20C). 
Therefore, the production of ROS likely contributes to necroptosis in c-FLIPL-deficient T 
cells.  
The major cellular reservoir of ROS production is the mitochondria (Hildeman et 
al. 2003). In T lymphocytes, the numbers of mitochondria are tightly regulated by 
autophagy (Jia and He 2011). However, the enhanced autophagy seems not to change 
the mitochondrial level in naïve and activated c-FLIPL T cells (Figure 21). RIP-1/RIP-3 
activation may also lead to increased ROS production (Yu et al. 2006; Van Herreweghe et 
al. 2010). Additionally, excessive autophagy causes ROS accumulation by degradation of 
catalase, the major ROS scavenger (Yu et al. 2006).  
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Figure 20: Increased ROS contributes to the necroptosis in c-FLIPL-deficient T 
cells. 
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Figure 20. (A) CM-H2DCFDA staining in c-FLIPL T cells. (B) DHE staining in c-
FLIPL T cells. Naïve and activated T lymphocytes (16 hours after anti-CD3 stimulation) 
were stained with CM-H2DCFDA (A) or DHE (B) and analyzed by flow cytometry. Data 
are representative of >3 experiments. (C) Antioxidant NAC improved the survival of c-
FLIPL T cells. Total splenocytes were stimulated with anti-CD3 and cultured for 40 
hour in the presence or absence of NAC and Nec-1. Cell death rates of T cells were 
analyzed by flow cytometry. Cell survival was tested by flow cytometry. Live cells were 
analyzed by gating on the Annexin V 7-AAD population within the total CD4 or CD8 
populations. 
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Figure 21: Unchanged mitochondrial volume in c-FLIPL-deficient T cells. 
Figure 21. Mitochondria volume in wild type and c-FLIPL T cells. The 
mitochondrial contents of naïve and activated T lymphocytes (16 hours after anti-CD3 
activation) were analyzed by flow cytometry based MitoTracker staining. Data are 
representative of >3 experiments. 
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3.3. Conclusion and Discussion 
3.3.1 The anti-necroptotic role of c-FLIPL in activated T cells 
Deletion of c-FLIPL in T cells resulted in dramatic cell death upon TCR 
stimulation. Although c-FLIPL has long been considered as an anti-apoptotic protein, 
activated c-FLIPL T cells showed extensive necroptosis. In contrast, naïve c-FLIPL T 
cells showed no defects in cell survival. More interestingly, though previous studies 
showed the occurrence of necroptosis when caspase 8 activity was totally blocked, we 
observed both necroptosis and enhanced caspase 8 cleavage in c-FLIPL-deficient T cells. 
Our results suggest that the anti-necrotic and pro-apoptotic activities of caspase 8 might 
be separately regulated. Moreover, the increased apoptosis and necroptosis observed in 
c-FLIPL-deficient T cells were both Fas-dependent.  
Necroptosis in c-FLIPL-deficient T lymphocytes upon TCR stimulation occurs 
downstream of Fas signaling. This finding is consistent with several recent publications 
showing that death receptor-induced necroptosis in Cyld MEFs, caspase-8 
hematopoietic cells and Fadd keratinocytes (Bonnet et al. 2011; Kaiser et al. 2011; 
O'Donnell et al. 2011). Caspase 8- or FADD-deficient T lymphocytes also show 
remarkable necroptosis upon TCR stimulation (Osborn et al. 2010; Ch'en et al. 2011), but 
whether Fas signaling induces necroptosis in these knockout models remains to be 
determined. Besides death receptor signaling, alternative necroptosis inducers may also 
exist. For example, TLR3 activation is shown to induce necroptosis in HaCaT 
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keratinocytes treated by z-VAD-fmk (Feoktistova et al. 2011). Therefore, future studies 
should focus on deciphering the signal pathway of necroptosis induction under 
physiological conditions and the biological implications of programmed necrosis. 
Necroptosis usually occurs when caspase 8 activity and apoptosis are blocked. 
Here, we reported the existence of necroptosis in cells with enhanced apoptosis. Our 
results provide important information for the understanding of the cellular mechanism 
of necroptosis regulation. Both enhanced apoptosis and necroptosis are downstream of 
Fas-FasL ligation in c-FLIPL-deficient T cells. When Fas is activated, multiple proteins, 
including c-FLIPL and pro-caspase 8, are recruited to the DISC (Budd et al. 2006). The 
fact that c-FLIPL, caspase 8, and FADD are all involved in necroptosis regulation 
strongly suggests that the inhibition of RIP-1/RIP-3 occurs in the DISC (Osborn et al. 
2010; Ch'en et al. 2011). The interaction between pro-caspase 8 and c-FLIPL in the DISC 
leads to the cleavage of c-FLIPL to generate p43FLIP (Budd et al. 2006). Both p43FLIP 
and c-FLIPL recruit RIP-1 to the caspase 8/c-FLIP/RIP-1 complex; and p43FLIP binds RIP-
1 with higher affinity than do full-length c-FLIPL or caspase 8 in T lymphocytes 
(Dohrman et al. 2005a). Studies in human fibroblasts showed that caspase 8 mediates the 
cleavage of RIP-1 to produce an inhibitory RIP-1 fragment (Rajput et al. 2011). It is 
possible that c-FLIPL contributes to the RIP-1 cleavage and inactivation in T 
lymphocytes. This hypothesis is supported by the accumulation of RIP-1 protein in c-
FLIPL-deficient T cells, while RIP-1 mRNA level is unchanged. c-FLIP may regulate RIP-
  122 
1 activity by recruiting RIP-1 to the DISC for caspase 8-dependent degradation. Without 
c-FLIPL, the recruitment of RIP-1 is blocked. Therefore, RIP-1 cannot be regulated by 
caspase 8 cleavage, leading to increased RIP-1 activity and necroptosis. Another 
possibility is that c-FLIPL-caspase 8 heterodimer, instead of active caspase 8 alone, is 
responsible for RIP-1 inhibition. These two hypotheses may be true at the same time. In 
the term of the regulation of apoptosis, the loss of c-FLIPL protein causes enhanced 
apoptotic caspase 8 activation (p18 generation) and a subsequent increase in apoptosis in 
c-FLIPL-deficient cells (Figure 22). 
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Figure 22: A proposed model for c-FLIP mediated regulation of apoptosis, 
necroptosis and autophagy 
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Figure 22. T lymphocytes upregulate the expression of Fas and FasL upon TCR- 
activation. The binding of Fas to FasL on the cell surface induces the formation of the 
DISC, where both c-FLIPL and c-FLIPR suppress the activation of pro-caspase 8 and 
downstream apoptosis. In addition, c-FLIPL and p43FLIP recruit RIP-1. c-FLIPL is 
required for inhibiting RIP-1 activity and necroptosis. Simultaneously, TCR activation 
induces autophagosome formation in T lymphocytes through an unknown mechanism. 
c-FLIP competes with LC3 for Atg3 binding, thereby reducing LC3 processing, and thus 
suppressing autophagy induction. In c-FLIPL-deficient T cells, autophagy is enhanced 
and protects cells from RIP-1-dependent necrosis. 
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Our study reveals that excessive ROS contributes to cell death in c-FLIPL-
deficient T lymphocytes upon TCR stimulation, which is consistent with previous 
reports showing that ROS accumulation leads to necroptosis in z-VAD-fmk treated L929 
cells (Yu et al. 2006; Chen et al. 2011). c-FLIPL-deficient T cells showed increase in 
hydrogen peroxide (stained by CM-H2DCFDA), but not in superoxide anion (stained by 
DHE). Cellular generation of hydrogen peroxide upon TCR stimulation is required for 
ERK phosphorylation upon TCR stimulations (Devadas et al. 2002). Therefore, enhance 
generation of hydrogen peroxide may be the reason that c-FLIPL-deficient T cells exhibit 
elevated ERK signaling (Zhang et al. 2008b) and increased proliferation capacity when 
cell death is blocked. Mitochondria may serve as the production site of ROS due to 
increased Ca2 flux and the alteration of metabolism, in which RIP-1 activity is involved 
(Van Herreweghe et al. 2010). Studies in L929 cells suggests that increased ROS is 
downstream of dysregulated autophagy (Yu et al. 2006; Chen et al. 2011). Whether 
enhanced autophagic flux in T cells leads to excessive ROS production remains to be 
determined. Our study showed that autophagy is generally cytoprotective for c-FLIPL-
deficient T cells. Nevertheless, it is possible that autophagy is upstream of both 
beneficial and harmful effects for cell survival and the combination of those effects 
determines the outcome. 
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3.3.2 The cytoprotective role of autophagy 
Our findings demonstrate that c-FLIPL suppresses autophagy in both activated 
and resting T lymphocytes, and the enhanced autophagy is cytoprotective. Autophagy 
supports cell survival in many circumstances, especially upon nutrient withdrawal 
(Gordy and He 2012). In T lymphocytes, autophagy is indispensable not only for 
surviving growth factor withdrawal, but also for regulating mitochondria and 
endoplasmic reticulum (Pua and He 2009b; Jia and He 2011; Jia et al. 2011). The anti-
apoptotic and anti-necroptotic protein c-FLIPL is involved in autophagy regulation. 
Previous report showed the various isoforms of c-FLIP controlled the threshold of 
autophagy when over-expressed in cells (Lee et al. 2009). Interesting, we observed 
autophagosomes enclosing multiple layers of membranes in c-FLIPL deficient T cells. 
These structures were absent in wild-type T cells. How autophagy promotes cell 
survival in c-FLIPL-deficient T cells remains to be determined. In addition to clearing 
unwanted intracellular substances and providing energy, autophagy may benefit 
activated c-FLIPL T cells in a more direct way: studies in cells resistant to apoptosis 
revealed that autophagy actively removed active caspase 8. Whether T lymphocytes 
employ a similar mechanism must be addressed in further studies. In addition, it will be 
interesting to investigate whether the enhanced autophagy observed in naïve c-FLIPL 
T lymphocytes renders them more resistant to cell death. 
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3.3.3 The caspase 8-c-FLIPL-FADD axel in the regulation of apoptosis, 
necroptosis and autophagy. 
Apoptosis can be triggered when death receptors on the cellular membrane meet 
their ligands (Zhang et al. 2005). When sensing the death signals, death receptors 
activate caspase 8, which in turn triggers the apoptotic cascade. However, blocking 
caspase 8 activity does not protect cells from the fate of death. Loss of caspase 8 activity 
leads to excessive RIP1/RIP3-dependent necroptosis (Walsh and Edinger 2010). In T 
lymphocytes, pro-apoptosis factor caspase 8, anti-apoptotic factor c-FLIPL and their 
adaptor protein FADD are all involved in the suppression of necroptosis. caspase-8 and 
Fadd T cells exhibit severe necroptosis, while c-FLIPL-deficient T cells shows enhanced 
apoptosis and necroptosis (Ch'en et al. 2011a; He and He 2013b). c-FLIPL inhibits 
apoptosis by suppressing active caspase 8 generation and prevents necroptosis by 
promoting caspase 8-dependent RIP-1 cleavage. 
A term “autophagic death” was used to describe the TNF- induced cell death in 
L929 cells, which showed high number of autophagsomes (Yu et al. 2004). The name 
seemed to be reasonable at that time, as inhibition of autophagy induction rescued the 
cell death. However, contrary results later appeared, arguing that the enhanced 
autophagy is protective, rather than detrimental for the cell survival (Osborn et al. 2010; 
Ch'en et al. 2011). We examined whether enhanced autophagy is cytoprotective in c-
FLIPL-deficient T cell using genetically modified mouse models in which the autophagy 
machinery is disabled. Inducible deletion of Atg3 in c-FLIPL T cells further reduced the 
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survival of activated c-FLIPL T cells. Meanwhile, short term loss of Atg3 did not impair 
T lymphocyte survival. Previous work showed that autophagy in peripheral T cells 
functions to removed excessive mitochondria and endoplasmic reticulum (ER), and is 
indispensable for TCR-induced proliferation (Pua et al. 2009; Jia and He 2011; Jia et al. 
2011). Here we found that in stressed cells (in which both apoptosis and necroptosis 
were induced), autophagy also played cytoprotective role.  
Several independent groups reported necroptosis in activated T lymphocytes 
when the functional caspase 8 activity was compromised (Bell et al. 2008; Osborn et al. 
2010; Ch'en et al. 2011a; Lu et al. 2011; He and He 2013b). Enhanced autophagy is 
usually detected in necroptotic cells, though whether it is the cause of cell death is 
debatable. The results from those models and our study are summarized in Table 1. 
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Table 1: The comparison of the phenotypes of caspase 8-, FADD- and c-FLIPL-
deficient T cells after TCR stimulation 
 Models Necroptosis 
Enhanced 
Autophagy 
Apoptosis 
Necroptosis  
rescued by 
Nec-1 
Necroptosis  
rescued by 
Rip-3
Autophagy- 
dependent 
cell death 
caspase-8 Yes  No  Yes No 
FADDdd Yes Yes No Yes Yes Yes 
Fadd Yes  No Yes  No 
c-Flip 
c-FLIPR Tg 
(c-FLIPL) 
Yes Yes Yes Yes  No 
 
Combined with previously published data from other groups, we present a 
model describing how c-FLIPL and caspase 8 regulate the interplay of autophagy, 
apoptosis and necroptosis (Figure 23). Still, several questions need to be answered to 
resolve the twisted relationships between these three fundamental intracellular events. 
First, though multiple studies investigate the interplay of autophagy and apoptosis, it is 
still unclear that the mechanism of how autophagy antagonizes apoptotic signals in c-
FLIPL-deficient T cells. Second, little is known about whether and how autophagy 
protects the cells from necroptosis. Reactive oxygen species (ROS) contributes to the 
necroptosis in c-FLIPL-deficient T cells. Autophagy regulates the major ROS resource, 
mitochondria (Pua et al. 2009). However, our results showed that the mitochondrial 
level were similar in wild type and c-FLIPL T cells. It is possible that autophagy may 
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contribute to remove damage organelles in c-FLIPL T cells to promote cell survival. 
Third, the mechanism of how necroptosis allies with enhanced autophagy needs to be 
addressed. Cell molecular study proved that c-FLIP proteins directly compete with LC3 
for Atg3 through two DEDs (Lee et al. 2009). Here we showed that c-FLIP is also a 
negative regulator for necroptosis. Therefore, the alteration of the expression level of c-
FLIP may correlate autophagy and necroptosis. However, the high level of autophagy in 
z-VAD-fmk treated L929 cells and in activated FADD-deficient T cells suggested that 
necroptotic conditions might induce autophagy that cannot be suppressed by 
endogenous c-FLIP. Other molecule must be altered during the necroptosis to promote 
autophagy induction. 
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Figure 23: c-FLIPL-mediated interplay of apoptosis, necroptosis and autophagy 
in T lymphocytes. 
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Figure 23. c-FLIPL controls apoptotic signaling (caspase 8) activities and 
downregulates autophagy. Together with pro-caspase 8 (with intact activity), c-FLIPL 
inhibits necroptosis induction in T cells. In the absence of c-FLIPL, autophagy, 
necroptosis and apoptosis are all enhanced. When caspase 8 is deleted or its proteolytic 
activities are inhibited, apoptosis is blocked. However, necroptosis is induced in the 
cells, as the catalytic activity of pro-caspase 8 is required for RIP-1 inhibition. The 
autophagy levels in caspase-8 T lymphocytes and Fadd cells have yet to be 
determined. 
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4. c-FLIP protects T lymphocyte from apoptosis in the 
intrinsic pathway  
4.1 Introduction 
c-FLIP has been shown to suppress death receptor-induced apoptosis. Death 
receptors ligation recruits pro-caspase 8 through adaptor protein (FADD or TRADD). 
The interaction between pro-caspase 8 molecules upon the recruitment leads to cleavage 
in their C-terminal and the release of the active caspase 8. Two isoforms of c-FLIP 
proteins are expressed in murine cells: 24 kD c-FLIPR and 55kD c-FLIPL. Both c-FLIPL 
and c-FLIPR suppress apoptosis by forming heterodimer with pro-caspase 8 to inhibit its 
proper activation (Budd et al. 2006). c-FLIP-deficient T cells showed defective survival, 
especially upon TCR stimulation. (Zhang et al. 2008a). Blocking extrinsic apoptosis 
pathway by ablating Fas and/or TNF-receptor expression results in limited 
improvement in the survival of c-FLIP-deficient T cells after TCR activation, which 
suggests that c-FLIP may protect cell survival in a death receptor-independent pathway. 
Therefore it is important to examine whether c-FLIP plays a role in regulating the 
intrinsic apoptosis pathway in T lymphocytes. 
c-FLIP regulates autophagy and necroptosis, two processes involved in cell 
survival (He and He 2013a). Autophagy is essential for T cell homeostasis. Deficiency in 
any following autophagy machinery molecules, Atg5, Atg3, Atg7 or Beclin-1, leads to 
impaired T cell survival (Pua et al. 2007; Pua et al. 2009; Stephenson et al. 2009; Hubbard 
et al. 2010; Jia and He 2011). However, suppressing autophagy under certain conditions 
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is beneficial for the survival of T lymphocytes (Bell et al. 2008). c-FLIP overexpression 
represses autophagy and improves cell survival in NIH3T3, MEF and HCT116 cells (Lee 
et al. 2009). Immunoprecipitation results in HCT116 cells demonstrates that c-FLIP binds 
to Atg3 and prevents Atg3 interacting with LC3, a process essential for autophagosome 
formation. Necroptosis is a type of programmed necrotic cell death, which is suppressed 
by caspase 8 activity. Loss of the long isoform of c-FLIP leads to necroptosis in T 
lymphocytes upon TCR stimulation (He and He 2013b). Meanwhile, necroptosis has not 
been detected in naïve T lymphocytes. Whether c-FLIP protects mature T cells through 
regulating autophagy and necroptosis needs to be determined. 
Previously we reported that c-FLIP conquers death receptor-induced apoptosis 
and primary TCR activation-induced cell death by inhibiting caspase 8 activation 
(Zhang et al. 2008a). Here we found that cell survival was impaired in naive c-FLIP-
deficient T lymphocytes, especially after apoptosis induction by staurosporine (STS). 
Besides moderating caspase 8 activity, c-FLIP suppressed mitochondrion-mediated 
apoptotic signaling. Necroptosis was not detected in naïve T lymphocytes no matter c-
FLIP proteins are expressed. V Autophagy was upregulated in c-FLIP-deficient T cells, 
but inhibition of autophagy did not improve cell survival in the absence of c-FLIP 
protein.  
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4.2 Results 
4.2.1 Impaired survival of c-FLIP-deficient T lymphocytes  
Conditional deletion of c-FLIP in the thymocytes leads to impaired survival and 
severe periphery T cells reduction (Zhang and He 2005b). The low cell number of c-
FLIP-deficient T cells, along with the accumulative effect of the deletion, makes this 
model unsuitable for studying the role of c-FLIP in mature T lymphocytes. Therefore, we 
crossed c-Flipf/f mice with ER-Cre mice to generate inducible c-FLIP knockout mice. As 
in vivo deletion of c-FLIP causes lethality of the animals within 3 days, c-FLIP was 
deleted in vitro in T lymphocytes by 4-hydroxy-tamoxifen to generate c-FLIP T cells  
(Zhang et al. 2008a). After deletion, live cells were purified and cultured with 1 ng/ml 
IL-7. The rate of apoptosis was analyzed after 16 hours in the absence or presence of 
apoptosis inducer staurosporine (STS) and etoposide (ETP). Staurosporine inhibits PKC 
kinase and induces caspase 3-dependent apoptosis in cells (Shimizu et al. 2004). 
Etoposide causes irreversible double-strand or single-strand breaks in DNA (Tenev et al. 
2011). The survival rate of c-FLIP-deficient T cells was significantly reduced compared to 
that of wild type cells, once apoptosis is induced by staurosporine. The survival of c-
FLIP-deficient T lymphocytes cultured in the absence of apoptosis-inducting drugs was 
also impaired compared to that of the control group, though the phenotype is much 
milder. However, genomic toxin etoposide did not trigger more cell death in c-FLIP-
deficient T cells than in wild type T cells (Figure 24A, B).  
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c-FLIP has been shown to regulate necroptosis in activated T lymphocytes (He 
and He 2013b). Therefore, we first determined whether staurosporine treatment induces 
necroptosis in c-FLIP-deficient T cells. The induction of apoptosis involves the activation 
of a series of caspases, which can be inhibited by pan-caspase inhibitor z-VAD-fmk. 
Necroptosis induction requires the activity of RIP-1 kinase, which can be repressed by 
necrostatin-1 (Nec-1) (Degterev et al. 2008). The enhanced death rate of c-FLIP T cells 
was partially rescued z-VAD-fmk, but not by Nec-1 (Figure 25). Addition of Nec-1 to z-
VAD-fmk treated T cells did not further increase cell survival. These data suggest that 
staurosporine-treated T lymphocytes die from apoptosis, not necroptosis. 
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Figure 24: Enhanced apoptosis in c-FLIP-deficient T lymphocytes. 
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Figure 24. (A) The rate of apoptosis in c-FLIP-deficient T cells. Lymphocytes 
pooled from spleen and lymph nodes from c-Flipf/f and c-Flipf/f ER-Cre mice were 
cultured for 3 days with 4-hydroxy-tamoxifen for in vitro deletion. Live cells were 
enriched with Ficoll then cultured in the presence or absence of staurosporine (STS) or 
etoposide (ETP) for 16 hours. Cell death was measured by Annexin V and 7-AAD 
staining. (B) Statistics of (A). Live cells were analyzed by gating on the Annexin V 7-
AAD population within the total CD4 or CD8 populations (n=6). All error bars represent 
the standard error of the mean (s.e.m.). 
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Figure 25: No necroptosis in the c-FLIP-deficient T cells 
Figure 25. Effect of necrostatin-1 and z-VAD-fmk on the cell death of c-FLIP T 
cells. Lymphocytes pooled from spleen and lymph nodes from c-Flipf/f and c-Flipf/f ER-
Cre mice were cultured for 3 days with 4-hydroxy-tamoxifen for in vitro deletion. Live 
cells were enriched with Ficoll then cultured in the presence or absence of STS, z-VAD-
fmk and Nec-1 for 16 hours. Apoptosis was measured by flow cytometry. Live cells were 
gated on the Annexin V 7-AAD population (n=6). All error bars represent the standard 
error of the mean (s.e.m.). 
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4.2.2 The protective role of c-FLIP in the intrinsic apoptosis pathway 
in naive T lymphocytes 
Caspase 1 and caspase 3 activation are involved in the apoptosis induction by 
staurosporine, though the mechanism of how staurosporine activate caspases is unclear 
(Krohn et al. 1998; Chae et al. 2000). Here we used inhibitors of different caspases to test 
which apoptotic pathway is activated. Extrinsic pathway of apoptosis is triggered by 
death receptor ligation, followed by activation of caspases 8. Intrinsic pathway is 
characterized by cytochrome c released from mitochondria to cytosol and the activation 
of caspases 9 by apoptosome (Zhang et al. 2005). The enhanced apoptosis of c-FLIP-
deficient T lymphocytes was partially rescued by both caspases 9 inhibitor z-LEHD-fmk 
and pan-caspase inhibitor z-VAD-fmk. Caspases 9 inhibitor z-LEHD-fmk showed better 
rescue effect, especially in CD4 T cells. Caspase 8 inhibitor z-IETD-fmk, however, failed 
to rescue the enhanced apoptosis in c-FLIP-deficient T lymphocytes (Figure 26A). Also, 
active form of caspase 8 could not be detected in either group of T cells (data not 
shown). The requirement of caspases 9 in staurosporine-induced apoptosis suggested 
the involvement of the intrinsic apoptotic pathway in c-FLIP-deficient T cells. Also, we 
detected cytochrome c release from mitochondria to cytosol in both wild type and c-
FLIP-deficient T cells. The kinetic study showed that cytochrome c release was faster in 
c-FLIP-deficient T cells than wild type controls (Figure 26B). These data indicate that c-
FLIP proteins protect T cells from also mitochondrial stress-induced apoptosis.  
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Figure 26: The regulatory role of c-FLIP in the intrinsic apoptosis pathway in T 
lymphocytes 
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Figure 26. (A) Effect of z-VAD-fmk, z-LEHD-fmk and z-IETD-fmk on the cell 
death of c-FLIP T cells. Inducible deletion was conducted as in Figure 23. Live T cells 
were then cultured in the presence or absence of z-IETD-fmk, z-LEHD-fmk or z-VAD-
fmk for 16 hours. Apoptosis was measured by flow cytometry based Annexin V/7-AAD 
staining. Live cells were analyzed by gating on the Annexin V 7-AAD population within 
the total CD4 or CD8 populations (n>4). All error bars represent the standard error of 
the mean (s.e.m.). (B) Cytochrome c release upon staurosporine. Live T cells were sorted 
after in vitro deletion of c-FLIP and cultured in the presence of staurosporine (STS) for 
indicated time. Cytosol was separated by digitonin in 80mM KCl buffer.  
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4.2.3 c-FLIP protects Bim-dependent apoptosis in naive T 
lymphocytes 
To confirm that c-FLIP interacted with intrinsic apoptotic pathway, we tested 
whether deletion of Bcl-2 family pro-apoptotic proteins rescues the enhanced cell death. 
c-Flipf/f ER-Cre mice were crossed with Bak, Bax and Bim mice to generate double 
knockouts. During apoptosis induction in the intrinsic pathway, Bak and Bax form 
oligomeric complex in the outer membrane of the mitochondria to mediate the release of 
cytochrome c (Mikhailov et al. 2003; Dejean et al. 2005). Bax and Bak frequently 
compensate for each other in the process of MOMP. BakBax cells show resistance to 
multiple death stimuli that mediates apoptosis through intrinsic pathway, while Bax- 
and Bak- deficient cells are susceptible to them (Wei et al. 2001). Deletion of Bak did not 
rescue the apoptosis phenotype of c-FLIP T cells (Figure 27A). Bax deficiency seemed 
to reduce the increased spontaneous apoptosis in c-FLIP T cells, but the result was not 
statistically significant (Figure 27B). Pro-apoptotic protein Bim responds to several 
stimulus and regulates the homeostasis of hematopoietic cells (Bouillet et al. 1999). Loss 
of Bim increased cell survival c-FLIP CD4 T cells, and fully rescued the cell death 
phenotype in c-FLIP CD8 T cells after staurosporine treatment. However, crossing to 
Bim mice only slightly reduced the spontaneous apoptosis in c-FLIP-deficient T cells 
(Figure 27C). These results suggest that c-FLIP protects staurosporine-induced apoptosis 
in T cells in a Bim-dependent pathway, while spontaneous apoptosis in c-FLIP-deficient 
T cells may be mediated by other mechanisms. 
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Figure 27: Bim-dependent apoptosis in c-FLIP-deficient T lymphocytes after 
staurosporine treatment 
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Figure 27. The effect of Bax, Bak and Bim deletion on the cell survival in c-FLIP-
deficient T cells. Splenocytes from c-Flipf/f, c-Flipf/f ER-Cre, c-Flipf/f Bak, c-Flipf/f ER-Cre 
Bak (A), c-Flipf/f Bax, c-Flipf/f ER-CreBax (B), c-Flipf/f Bim and c-Flipf/f ER-CreBim 
(C) mice were culture for 3 days with 4-hydroxy-tamoxifen for in vitro deletion to 
generate wild type, c-FLIP, Bak, c-FLIPBak (A), Bax, c-FLIPBax (B), Bim 
and c-FLIPBim (C) T cells. Live cells were enriched then cultured in the presence or 
absence of staurosporine (STS) for 16 hours. The cell survival rates were analyzed by 
flow cytometry based Annexin V/7-AAD staining. Live cells were gated on the Annexin 
V 7-AAD population within the total CD4 or CD8 populations (n>=4). All error bars 
represent the standard error of the mean (s.e.m.).  
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We next examined the expression level of Bcl-2 family member in c-FLIP-
deficient T cells. The expression levels of pro-apoptotic protein Bcl-2, Mcl-1 and Bcl-xL 
were comparable between wild type and c-FLIP T cells. After staurosporine treatment, 
Bcl-2 and Mcl-1 were downregulated in wild type cells, while the expression of Bcl-xL 
was increased (Figure 28). c-FLIP-deficient T cells failed to upregulate Bcl-xL, but 
showed higher expression of Mcl-1. Previous studied showed c-FLIP interacts with Bcl-
xL (Han et al. 1997). How this interaction regulates the function of Bcl-xL remains to be 
studied. Interestingly, the survived wild type and c-FLIP-deficient T cell after apoptosis 
induction showed decreased level of Bax and Bim (Figure 28), which may be the 
consequence that cells expressing low level of pro-apoptotic proteins preferentially 
survived. These data suggest the crosstalk between c-FLIP and Bcl-2 family members in 
the regulation of apoptosis in T lymphocytes.  
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Figure 28: The expression of Bcl-2 family members in c-FLIP-deficient T cells 
Figure 28. Western blot analysis of pro-apoptotic proteins in c-FLIP T cells. 
Total splenocytes from c-Flipf/f and c-Flip f/f ER-Cre mice were cultured for 3 days in the 
presence of 4-hydorxy-tamoxifen and IL-7 to induce deletion, resulting in wild type 
(WT) and c-FLIP (KO) lymphocytes. Live cells were purified by Ficoll and T cells were 
negatively enriched by selection kit. Enriched T cells were cultured in the absence or 
presence of STS for 6 hours, and then the cell lysate is analyzed by western bot. The 
expression level of each protein was quantified and normalized to the expression of 
Tubulin. The numbers underneath each band showed the relative expression level of 
each molecule compared to that in the wild type untreated T cells.  
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4.2.4 Autophagy is not involved in the enhanced apoptosis in c-FLIP-
deficient T lymphocytes 
We next tested whether c-FLIP modulated autophagy in T lymphocytes and 
whether autophagy was involved in the enhanced apoptosis in c-FLIP-deficient T cells. 
The conversion of LC3-I to LC3-II isoform and the consequent insertion of LC3-II in the 
isolation membrane are essential for autophagosome formation. Monitoring LC3 puncta 
formation inside the cells is wildly applied in autophagy detection (Klionsky et al. 2012). 
Here we tested the level of LC3-II in c-FLIP-deficient and wild type T cells by western 
blot. LC3-II was undetectable in both wild type and c-FLIP-deficient T cells in the 
absence of apoptosis stimuli. After staurosporine treatment, LC3-II was increased, 
especially in c-FLIP-deficient T cells (Figure 29A). We then intracellularly stained c-FLIP-
deficient T cells and wild type cells with anti-LC3 to examine the LC3 puncta as the 
signs of autophagosome. The number of LC3 puncta in c-FLIP T cells was not 
significantly higher than that in wild type T cells. However, c-FLIP-deficient T cells 
showed larger LC3 puncta and stronger fluorescent intensity, indicating larger 
autophagosome formed or higher LC3 protein level (Figure 29B). We then examined 
whether blocking autophagy alter the cell survival in c-FLIP T lymphocytes. Loss of 
autophagy related gene Atg3 in T lymphocyte leads to inhibition of autophagy (Jia and 
He 2011). Short term deletion of Atg3 does not cause increased apoptosis in naïve T cells 
(He and He 2013b). Therefore, c-Flipf/f ER-Cre mice were crossed to Atg3f/f mice to 
generate Atg3f/f c-Flipf/f ER-Cre mice. Atg3f/f c-Flipf/f littermates were used as controls. 
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Inducible deletion of c-FLIP and Atg3 was conducted successfully in vitro by 4-hydroxy-
tamoxifen (He and He 2013b). We found that deletion of Atg3 showed no impact on the 
cell survival in the presence of staurosporine. In the absence of staurosporine, the 
spontaneous apoptosis in CD4 T cells was unchanged, while the spontaneous apoptosis 
of CD8 T cells was increased in Atg3c-FLIP cells compared to that in Atg3c-
FLIP T cells (Figure 29B). These data suggests that autophagy is not the cause of the 
enhanced apoptosis of c-FLIP-deficient T lymphocytes. 
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Figure 29: Enhanced autophagy and autophagy-independent cell death in c-
FLIP-deficient T lymphocytes. 
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Figure 29. (A) Western blot analysis of LC3 in c-FLIP-deficient T cells. Total 
splenocytes from c-Flipf/f and c-Flipf/f ER-Cre mice were cultured for 3 days in the 
presence of 4-hydorxy-tamoxifen and IL-7 to induce deletion, resulting in wild type and 
c-FLIP lymphocytes. Live cells were purified by Ficoll and T cells were negatively 
enriched by selection kit. Live T cells were treated with staurosporine (STS) for 0, 3 and 6 
hours and lysed by sample buffer. The data shown are representative of 3 independent 
experiments. (B) LC3 puncta in c-FLIP-deficient T cells. Inducible deletion was induced 
as in (A) in T cells, and enriched live T cells were stimulated with anti-CD3 for 12 hours. 
Cells were intracellularly stained with anti-LC3 and examined by 3-D fluorescent 
microscopy. LC3 puncta represents LC3 dots (>10 pixels). Area represents relative LC3 
positive volume inside one cell. Total intensity represents the total LC3 signal from each 
cell (n>30). (C) The effect of autophagy inhibition in the survival of c-FLIP T cells. Total 
splenocytes from c-Flipf/f Atg3f/f, c-Flipf/f Atg3f/ ER-Cre and c-Flipf/fAtg3f/f ER-Cre mice 
were cultured for 3 days in the presence of 4-hydorxy-tamoxifen and IL-7 to generate 
wild type, c-FLIPAtg3 and c-FLIPAtg3 T cells. Live cells were isolated and 
cultured in the presence of absence of staurosporine for 16 hours with IL-7. Live cells 
were analyzed by gating on the 7-AAD population within the CD4 or CD8 
populations. All error bars represent the standard error of the mean (s.e.m.) (n>=4). 
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4.2.5 The role of reactive oxygen species in the enhanced apoptosis 
in c-FLIP-deficient T lymphocytes 
Staurosporine has been shown to rapidly increase intracellular reactive oxygen 
species (ROS) in HeLa cells. The high level of ROS contributes to caspase 3 activation 
and apoptosis induction (Shimizu et al. 2004). Notably, the long isoform of c-FLIP has 
been shown to promote cell survival by controlling ROS in activated T lymphocytes (He 
and He 2013b). Therefore, it was important to test whether ROS caused the increased 
apoptosis in staurosporine treated c-FLIP-deficient T lymphocytes. However, our results 
showed that loss of c-FLIP did not alter ROS production in naive T cells, in the presence 
or absence of staurosporine (Figure. 30A). Addition of antioxidant NAC moderately 
improves the cell survival after the staurosporine treatment in both wild type and c-
FLIP-deficient T cells (Figure. 30B). This result is consistent with the previous 
publication showing ROS is involved in the apoptosis induction by staurosporine 
(Shimizu et al. 2004). However, the protection of NAC was not specific to c-FLIP-
deficient T cell. These results suggest that c-FLIP protects naive T cells in a ROS-
independent pathway.  
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Figure 30: ROS-independent enhanced apoptosis in c-FLIP-deficient T cells. 
Figure 30. (A) ROS levels in c-FLIP-deficient T cells. Live naïve T lymphocytes 
were cultured in the absence of presence of staurosporine for 16 hours. Cells were then 
stained with DHE and analyzed by flow cytometry. Data are representative of 3 
independent experiments. (B) The effect of acetylcysteine on the survival of 
staurosporine treated T cells. Lymphocytes were cultured as in (A) in the presence or 
absence of NAC. Cell death rates of T cells were analyzed by flow cytometry. Live cells 
were analyzed by gating on the 7-AAD population within the CD4 or CD8 
populations. All error bars represent the standard error of the mean (s.e.m.) (n>=4). 
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4.3 Conclusion and Discussion 
Here we showed higher rate of death receptor-independent spontaneous 
apoptosis in c-FLIP-deficient T cells in the presence of survival factor IL-7. The apoptosis 
phenotype is much more severe when apoptosis was induced by staurosporine. The 
enhanced apoptosis in c-FLIP-deficient T cells resulted from more rapid cytochrome c 
release and following caspase 9 activation. The autonomous activation of pro-caspase 8 
was not the cause of the apoptotic phenotype in c-FLIP-deficient T lymphocytes. 
Notably, c-FLIP suppressed BH3-only pro-apoptotic protein Bim to regulate T cell 
survival upon apoptotic stimuli treatment. Deletion of Bim significantly improved the 
survival of c-FLIP T cells in the presence of staurosporine. Though autophagy is 
enhanced in c-FLIP-deficient T cells, inhibition of autophagy failed to rescue the 
enhanced apoptosis. 
c-FLIP-deficient T cells were susceptible to staurosporine-induced apoptosis, but 
showed similar apoptotic rate after etoposide treatment. The variable susceptibility of c-
FLIP-deficient T cells in these conditions is probably the consequence that different 
apoptotic stimuli are sensed by different pro-apoptotic molecules in the cell. For 
example, Noxa targets Mcl-1 for proteasomal degradation in response to DNA damage 
(Ploner et al. 2008). Puma is shown to be the predominant mediator in -radiation-
induced apoptosis in T lymphocytes (Erlacher et al. 2005). IL-7 deprivation-induced 
apoptosis, on the other side, is majorly mediated by Bim (Li et al. 2010). Etoposide and 
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staurosporine probably provoke apoptosis in distinct pathways. Etoposide induces 
apoptosis though generating double strand or single strand break in the genomic DNA 
(Tenev et al. 2011), while staurosporine inhibits PKC kinase and induces caspase 3-
dependent apoptosis (Shimizu et al. 2004). Here we showed that c-FLIP protected T cells 
from staurosporine-induced apoptosis in a Bim-dependent pathway. Therefore, Bim is 
likely to be the responding sentinel upon staurosporine treatment. Our results provide 
insights in understanding the cellular process of staurosporine-induced apoptosis. 
Enhanced intrinsic apoptotic signal in naïve c-FLIP-deficient T cells after 
staurosporine treatment is not the secondary effect of spontaneous caspase 8 activation. 
In Fas-induced apoptosis (extrinsic pathway), active caspase 8 cleaves Bid, a BH3-only 
pro-apoptotic protein, to generate the truncate form (tBid). tBid efficiently inserts into 
mitochondrial outer membrane and augments cytochrome c release (Li et al. 1998). It has 
been shown that c-FLIP-deficient T cells have higher caspase 8 activity after TCR 
activation (Zhang et al. 2008a). In the absence of death receptor signaling, loss of c-FLIP 
may result in higher level of caspase 8 autolysis. Our data suggests that caspase 8 
activity is not the cause of increased apoptosis in c-FLIP-deficient T cells. The 
intracellular level of active caspase 8 in naïve T cells is too low to be detected (data not 
shown). Also, caspase 8 inhibitor z-IETD-fmk showed no rescue in the cell death 
phenotype of c-FLIP-deficient T cells. Therefore, though caspase 8 augments cytochrome 
c release upon Fas ligation via tBid, it is not likely to do so in naïve T cells in the absence 
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of death receptor ligands. These results are consistent with the previous findings that the 
full activation of initiator caspases requires the assembly of a multi-component complex 
(Riedl and Shi 2004). Caspase 9-activating apoptosome can be assembled in naïve T cells 
after Bax/Bak-mediated MOMP and cytochrome c release. However, caspase 8-
activating DISC cannot be formed, due to the lack of extrinsic apoptotic signals. 
Our results suggested a strong correlation of c-FLIP deficiency and intrinsic 
apoptotic signaling in naïve T cells. Caspase 9 inhibitor z-LEHD-fmk and pan-caspase 
inhibitor z-VAD-fmk showed remarkable protection in c-FLIP-deficient T cells upon 
staurosporine treatment. c-FLIP protected cells from apoptosis induction by 
antagonizing pro-apoptotic BH3-only protein Bim. Interesting, Bim deficiency did not 
improve the survival rate of untreated naïve c-FLIP T cells. How c-FLIP regulates Bim 
is still unclear. On the other side, Bax deletion barely improved cell survival in naïve T 
cells. In HIV gp120 protein treated Jurkat cells, c-FLIPL suppresses apoptosis by 
promoting PKC protein expression and PKC-associated inactive Bax (Wang et al. 2009). 
However, our results showed that c-FLIP protected the survival of naïve T cells 
independent of Bax. One of the reasons may be that c-FLIPR is the dominant form of c-
FLIP protein in naïve T cells instead of c-FLIPL. 
Staurosporine treatment induces superoxide production and subsequent cell 
death in hippocampal neurons (Krohn et al. 1998). Here we showed that ROS 
production also contributed to the enhanced apoptosis in staurosporine treated T 
  157 
lymphocytes. Antioxidant NAC partially rescued the staurosporine-induced apoptosis. 
However, the cytoprotective effect of NAC was not specific to c-FLIP-deficient T cells. 
Our results showed that loss of c-FLIP did not increase the production of ROS in naïve T 
cells. Activated T cells, on the other side, require the long isoform of c-FLIP to regulate 
cellular ROS. Loss of c-FLIPL leads to increase ROS production and ROS-dependent cell 
death (He and He 2013b). These results suggest that c-FLIP proteins function differently 
in naïve and activated T lymphocytes. 
Necroptosis was not detected in naïve c-FLIP T cells. This result was consistent 
with previous publications showing necroptosis induction only in activated T 
lymphocytes (Bell et al. 2008; Osborn et al. 2010; Ch'en et al. 2011a; Lu et al. 2011). Why 
activated T cells are susceptible to necroptosis has yet to be studied. RIP-1 kinase plays 
an important role in T lymphocytes for proper TCR signaling. RIP-1-deficient T cells 
showed impaired TCR-induced phosphorylation of p65 NF-B (Zhang et al. 2011). 
Activated T cells may upregulate RIP-1 for the benefit of cell signaling, while loss of 
adequate inhibition in RIP-1’s kinase activity ends up killing the cells. In this scenario, 
the upregulation of RIP-1 is unlikely mediates by transcription, because necroptosis 
occur promptly after TCR activation. Our hypothesis is that there may be two “layers” 
of inhibition on RIP-1. TCR signaling release some inhibition on RIP-1, but the catalytic 
activity of caspase 8-c-FLIPL heterodimer is still sufficient to constrain RIP-1 
phosphorylation. When caspase 8 activity is blocked or c-FLIPL is deleted, RIP-1 loses 
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the second layer of suppression and undergoes phosphorylation, probably with the aid 
of RIP-3. One potential player in the “first layer of inhibition” is deubiquitinating 
enzyme CYLD. CYLD functions in the proximal TCR signaling by promoting the 
recruitment of ZAP70 to deubiquitinated Lck (Reiley et al. 2006). CYLD is upregulated 
in activated T lymphocytes and deubiquitinates RIP-1, a necessary process for the 
phosphorylation of RIP-1 (Harhaj and Dixit 2012). Another possibility is that the 
intracellular translocation of RIP-1 contributes to TCR activation induced-RIP-1 kinase 
activity. Upon TCR stimulation, RIP-1 is recruited to caspase 8 and c-FLIPL (Dohrman et 
al. 2005a). This process provides a docking site for RIP-1 to interact with each other and 
potentially undergo autophosphorylation. Death receptor Fas may be involved in the 
recruitment of RIP-1 through mediating the formation of DISC. Our results showed that 
Fas was indeed required for the induction of necroptosis, at least in c-FLIPL-deficient T 
lymphocytes. These two hypothesized mechanism do not contradict to each other and 
may both be true in the cells. 
Altogether we showed that c-FLIP regulates apoptosis signaling in the Bim-
dependent intrinsic pathway. The mechanism of the crosstalk of c-FLIP and Bim remains 
to be determined. Our results suggest that c-FLIP protein protects T lymphocytes 
survival through multiple pathways. 
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